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Abstract 
Background: Extracellular vesicles (EVs) are nanoscale (30 to 1000 nm diameter) mediators of intercellular 
information transfer, shuttling diverse cargos including functional nucleic acids, proteins and lipids. EVs are released 
by all cell types, are stable in circulation and are thus capable of transferring information between distant tissues. It 
has been established that circulating EV profiles adapt to differing physiological and disease states. However, a 
paucity of information on this type of communication arising from skeletal muscle is apparent, especially in the 
context of exercise. This is despite multiple opinion reviews highlighting the importance of EVs and their cargo 
(particularly microRNA) as biomarkers of muscle myopathies/dystrophies/damage and even as ameliorators of 
chronic diseases associated with a sedentary lifestyle.  
Aims: To determine whether circulating EVs, within the exosome size range, display size, number and cargo 
alterations in response to exercise-induced muscle damage (EIMD) from an acute bout of eccentrically-biased 
exercise. Specific cargo selected for analysis included: miR-1, 133a, 133b, 206 and 31. 
Methods: Blood samples were drawn from 9 human volunteers at baseline (BL), 2 and 24 hours after acute, 
sequential plyometric jumping and downhill running bouts. Leg muscle pain was assessed on a scale from 1 to 10. 
Serum creatine kinase (CK) activity was quantified spectrophotometrically. Plasma exosomes were isolated using size 
exclusion columns and visualised with transmission electron microscopy (TEM). Quantitative and qualitative 
information on exosome protein was determined by micro-bicinchoninic acid assays and Coomassie-stained gel 
visualisation respectively.  Exosome sizes and numbers were quantified by nanoparticle tracking analysis (NTA). 
Selected microRNA (miR) cargo was reverse transcribed, and quantified using qPCR with normalisation to an 
exogenous control (cel-miR-39). 
Results: Perceived muscle pain and serum CK were elevated post-exercise, providing indirect evidence for EIMD. A 
simplified protocol for fast exosome visualisation using TEM was achieved, and revealed an abundance of exosomes 
of varying sizes. A concomitant abundance of exosomes was found using the more precise NTA technique (mean = 9 x 
1010 exosomes/ml plasma). Mean exosome diameters were 127 ± 15 nm across all timepoints. No change in exosome 
size or number was seen over time. Similarly, no change in exosome total protein concentration was apparent 
between timepoints. Exosome enrichment of the skeletal muscle-specific miR-206 was detected in all but one 
participant. Neither miR-206, nor ubiquitous myomiRs-1, -133a and -133b changed across timepoints. However, 
exosome miR-31 decreased from BL to 24 hr post-exercise (p < 0.05). Grouping of participants according to increases 
(responders) or decreases (non-responders) in exosome number from BL to 24 hr post-exercise revealed that 
exosome miR-133b decreased between BL and 24 hr post-exercise (p < 0.05) in non-responders (n = 6), with no 
characteristic change present in responders. 
Conclusion: A profuse number of exosomes is present in human plasma. NTA analysis revealed that size exclusion 
was an effective exosome isolation method. Following EIMD the number or sizes of circulating exosomes did not 
change.  Rather, exosome cargo profiles changed. Decreased exosome miR-31 following EIMD suggests the specificity 
of the response, with differences in response noted between responders and non-responders.  
Stellenbosch University  https://scholar.sun.ac.za
iii 
Uittreksel 
Agtergrond: Ekstrasellulêrevesikels (EVs) dien as vervoermiddels van biologiese vrag en groottes is op nanoskaalvlak (30 to 
1000 nm deursnee). EVs word vrygestel deur alle seltipes en is stabiel in sirkulasie, wat hul gepas maak om informasie 
intersellulêr te vervoer in die vorm van funksionele nukleïensure, proteïene en lipiede. Dit is voorheen vasgestel dat 
sirkulerende EV profiele aanpas volgens veranderinge in gesonde of ongesonde fisiologiese toestande. Desnieteenstaande 
bestaan daar ‘n gebrek aan inligting vir skeletspier geassosieerde EVs, veral in die konteks van oefening. Ongeag hiervan 
het verskeie opinie resensies die gebruik van EVs en hul vrag (veral mikroRNS) as biomerkers vir spier 
miopatie/distrofie/beserings beklemtoon, asook hul potensiaal as genesingsmediators vir die kroniese siektes van ‘n 
onaktiewe lewenswyse. 
Doelwitte: Om te bepaal of ‘n verandering in die grootte, getal en vrag van sirkulerende EVs, binne die eksosoom grootte 
beperking, veroorsak word deur oefening-geïnduseerde spierskade (OGSS), teweeggebring deur ‘n eksentries-
bevooroordeelde oefeningsessie. Spesifieke vragte geselekteer vir ontleding sluit in: miR-1, 133a, 133b, 206 en 31. 
Metodes: Bloedmonsters van 9 menslike vrywilligers was geneem by basislyn (BL), 2 en 24 ure na akute, opeenvolgende 
pleometriese spronge en afdraand hardloopsessies. Beenspier pyn was geasesseer (skaal van 1 tot 10). Serum kreatien 
kinase (KK) aktiwiteit was spektrofotometries gekwantifiseer. Plasma eksosome was geïsoleer deur gebruik te maak van 
grootte uitsluitings kolomme en gevisualiseer dmv transmissie elektron mikroskopie (TEM). Kwantitatiewe en kwalitatiewe 
informasie vir eksosoom proteïene was bepaal deur mikro-bisinkoninieksuur toetse en Coomassie-kleuring van kladde 
onderskeidelik. Eksosoom groottes en hoeveelhede was gekwantifiseer dmv nanopartikel opsporings analise (NOA). Die 
geselekteerde mikroRNS (miR) was agteruit getranskribeer en gekwantifiseer met kPCR. En data is genormaliseer deur 
eksogene kontrole (cel-miR-39). 
Resultate: Waargenome spierpyn en serum KK was verhoog na oefening en dui op indirekte wyse na OGSS. ‘n 
Vereenvoudigde protokol vir spoedige EV visualisering dmv TEM was opgestel, wat ‘n oorvloed van EVs van verkeie 
groottes ontbloot het. ‘n Gepaardgaande oorvloed van eksosome was gevind met gebruik van die akurate NOA tegniek 
(gemiddeld 9 x1010 eksosome/ml plasma). Gemene eksosoom deursnee was 127 ±15 nm vir alle tydintervalle. Geen 
verandering in eksosoom grootte profiel of getal was met die verloop van tyd waargeneem nie, asook nie in totale 
eksosoom proteïen konsentrasie nie. Eksosoom vermeerdering van die skeletspier-geassosieerde miR-206 was gevind vir 8 
van die 9 vrywilligers. Die hoeveelheid miR-206 asook alomteenwoordige myomiRs-1, 133a en 133b het onveranderd gebly 
tussen tydintervalle. ‘n Afname in eksosoom miR-31 was wel waargeneem vanaf BL tot 24 uur na-oefening (p<0.05). 
Groepering van deelnemers volgens toenames (reageerders) of afnames (nie-reageerders) in eksosoom hoeveelhede vanaf 
BL tot 24 uur na-oefening het aan die lig gebring dat eksosoom miR-133b verminder het tussen tydintervalle (p<0.05) slegs 
in nie-reageerders (n=6). 
Afsluiting: ‘n Oorvloed van eksosome is teenwoordig in menslike plasma. NOA analise beaam dat grootte uitsluiting ‘n 
effektiewe eksosoom ontginningsmetode was. Na afloop van OGSS het die profiel van die eksosoom vrag gedeeltelik 
verander, alhoewel die getal en grootte van sirkulerende eksosome onveranderd gebly het. ‘n Vermindering slegs in 
eksosoom miR-31 na OGSS beklemtoom spesifisiteit. Verskillende reaksies is tussen reageerders en nie-reageerders 
waargeneem. 
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Chapter 1: Skeletal muscle 
 
1.1 Introduction 
Skeletal muscle (SkM) is a large tissue that constitutes approximately 40% of lean body mass in 
humans. SkM is at the center of numerous physiological processes eg. the expenditure of ATP to 
maintain core body temperature, force production for movement and the storage of proteins, 
fats and carbohydrates (i.e. structural proteins, triglycerides and glycogen, respectively). SkM is 
constantly required to synchronise local and systemic communication to maintain homeostasis 
and the ability to perform efficient work. This is not only necessary in healthy individuals, but 
also in circumstances where individuals rely on muscle breakdown as a source of energy (eg. 
cachexic patients), or those needing to compensate for decreased functional capacity due to 
muscle wasting (eg. in the condition known as sarcopenia).   
Myopathies and dystrophies are degenerative conditions of SkM that can either be inherited or 
acquired, and result in a significantly decreased capacity for muscular work 1. At present, 
limited treatment strategies are available for Duchenne muscular dystrophy, cachexia and 
sarcopenia patients. This is despite muscle damage having been of concern to researchers since 
the 1950’s, when 14 studies were published (PubMed search terms: “muscle damage” NOT 
“cardiac” NOT “heart”) on such diverse forms as; ischemic damage resulting from battlefield 
injuries 2, workplace nerve injuries leading to atrophy 3 and muscle complications of hemophilia 
4.  
SkM injuries in amateur and professional sport are also a routine occurrence, whether in 
training or competition. A detailed understanding of molecular and cellular events that occur 
during muscle injury and repair is essential to the development of intervention strategies that 
can enhance efficiency of regeneration and reduce recovery times. Such improved 
understanding will also aid in the development of strategies to delay muscle disease 
progression. The importance of SkM research becomes evident when one considers that the 
decade between 2006 and 2015 yielded 7728 publications on muscle damage (using the same 
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search terms listed above). The vast number of new publications per year is indicative of new 
information on muscle damage continuously being uncovered. It is not within the scope of this 
thesis to review all this research comprehensively. Instead, this literature review will start with 
an introductory overview of key processes/issues in skeletal muscle damage (Chapter 1), and 
then proceed to a more detailed review of extracellular vesicles (Chapter 2), key studies 
involving extracellular vesicles, and the position of skeletal muscle research in this emerging 
field (Chapter 3).  
1.2 A brief overview of skeletal muscle structure 
Skeletal muscle is connected to bone by integrated, tough and fibrous tendons. Muscle 
contractions cause a pull on tendons that results in movement of the connected bone. Whole 
skeletal muscle is comprised of abundant myofibres held together in bundles by perimysium 
connective tissue (Figure 1.1). The perimysium is surrounded by the epimysium which connects 
to the strong myotendinous junction. This network of connective tissue is not only necessary for 
force to be transferred to the bones, but also provides resilience and protection from stretch-
induced damage. Muscle is supplied by large blood vessels embedded in the perimysium 
(Figure 1.1). Considering the myofibres themselves, each is multinucleated and surrounded by a 
sarcolemma. A vast network of capillaries is intimately linked to the myofibre bundles, so that 
oxygen, nutrients and other biological molecules (e.g. hormones, cytokines, growth factors) can 
reach each myofibre readily. Similarly, the capillary network has a venous side, removing 
products of muscle metabolism and other factors (examples of which will be discussed in the 
forthcoming sections of this, and the next chapter). 
   
 




Figure 1.1. Brief overview of whole skeletal muscle structure. Figure from Scime et al with permission 5. 
 
1.3. Introduction to skeletal muscle damage and regeneration 
Sarcomeres, the functional unit of SkM, are responsible for tension development and the 
resultant contraction of the myofibre. Contraction of multiple myofibers is synchronised across 
the muscle to allow for sufficient tension. At the molecular level, sarcomeres are shortened 
through the action of myosin heads pulling on actin chains. To allow for significant force 
development, these two contractile proteins are sturdily held in place by Z-lines. Z-lines, in 
turn, are linked together by the abundant myoprotein, desmin. The large, elastic protein, titin, 
connects myosin tails to Z-lines, and allows the sarcomere to readily return to a resting position 
following contraction. However, contraction at the sarcomere level is not always synchronised 
and individual sarcomeres can become damaged during normal contraction. It is in fact its role 
in tension development that makes SkM a common site for injury. A theory of “popping 
sarcomeres” has been described in detail by D. Morgan in 1990 6. In this theory, weaker 
sarcomeres “pop” when muscle is stretched beyond it’s normal length-tension relationship i.e. 
when myosin heads no longer overlap with actin chains. Some types of contraction make it 
more likely for such damage to occur (see Morgan and Proske, 2004 7).   
Stellenbosch University  https://scholar.sun.ac.za
4 
 
The diversity of SkM injuries in humans ranges from damage of weaker sarcomeres to 
traumatic tears of the whole muscle. Although the magnitude of injury may differ substantially, 
all require a highly effective regenerative response. Indeed, SkM exhibits great regenerative 
capacity, largely owing to a resident pool of myoblast progenitor cells, known as satellite cells 
(SCs) 8. However, SCs do not operate as an independent entity. At the heart of SkM 
regeneration is a symphony of endocrine and paracrine signaling involved in local and 
widespread biological communication. Broadly, regeneration of SkM can be grouped into 
phases of inflammation, proliferation and differentiation, each with particular aspects of 
communication predominating 9. 
1.3.1 Inflammation 
Following damage, a complex secretome of cytokines and chemokines (i.e. collectively termed, 
myokines) is released by SkM into circulation. This systemic communication attracts pro-
inflammatory immune cells to the damaged area. Neutrophils are some of the first circulating 
cells to infiltrate, releasing pro-inflammatory factors that create a positive feedback loop for the 
attraction of more immune cells 10. During this initial inflammatory stage, neutrophils release 
proteolytic enzymes, such as matrix metallo-proteases and myeloperoxidase, and reactive 
oxygen species to degrade the damaged tissue and allow for complete destruction of the 
damaged area 11. This can be visualised as a loss of ultrastructural organization (i.e. a lack of 
striated appearance in the damaged area, and Z-line streaming) 12. Macrophages, displaying an 
M1 phenotype (i.e. pro-inflammatory), are next to infiltrate the area during overlapping phases 
of muscle destruction and phagocytosis of the resultant cellular debris 9. The pro-inflammatory 
cytokine, IL-6, is one of the most abundant circulating cytokines following muscle injury 13. The 
known responsiveness of macrophages to IL-6 signaling is an example of the organised and 
sequential immune response to molecular communication arising from muscle damage 14.  
1.3.2 Proliferation 
Following destruction and removal of debris, SC proliferation allows for the replacement of lost 
muscle cells and the restoration of fibre integrity if the damage is not severe enough for the 
entire fibre to be destroyed. These progenitor cells exhibit vast proliferative potential, and are 
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responsible for the high regenerative plasticity of SkM 15. SCs are uniquely positioned on the 
inside of the basal lamina, and on the outside of the sarcolemma 8. Their location allows for 
sensitive receival of both local and systemic communication. Hepatocyte growth factor (HGF), 
through resultant intracellular signaling after binding to c-met receptors, is a known activator of 
SCs. HGF is released by numerous cell types in the early phases of injury and degeneration, 
aiding SC activation. 
The intricate control of proliferation and differentiation in myogenesis is largely achieved by a 
group of transcription factors, known as Myogenic regulatory factor (MRFs). This group 
includes; Myogenic differentiation factor 1 (MyoD), Myogenic factor 5 (Myf5), Myogenin 
(MyoG) and Myogenic factor 6 (MRF4) (Figure 1.2). MRFs are known to interact with a plethora 
of local and systemic signals (i.e. growth factors, microRNAs, cytokines). Two of the MRFs, 
MyoD and Myf5, are key during proliferation. MyoD is considered a “master regulator” of 
myogenesis due to its influence in cellular commitment to a myogenic profile. This role of 
MyoD is substantiated by its ability to commit cells with or without a mesodermal lineage, to a 
myogenic phenotype 16. MyoD levels are increased following SC activation, and remain integral 
until the completion of differentiation. Myf5 is of most importance in maintaining the SC pool 
by designating some proliferating SCs to return to quiescence. Myf5 expression decreases as 
myogenesis progresses 17. 
1.3.3 Differentiation 
The differentiation/remodeling phase of regeneration is of most importance in determining the 
future function of the tissue. Insufficient structural reorganization of the regenerating area can 
result in a less efficient and less effective fibre. As a tissue recruited for work, SkM is reliant on 
an efficient and sturdy structure. The great capacity of SkM remodeling is largely responsible 
for this tissue’s advanced regenerative plasticity.  
During the remodeling phase in vivo, Macrophages displaying an M2 phenotype (i.e. 
regenerative) predominate 9. Within new myoblasts, derived from SC proliferation, MyoG and 
MRF4 are of most important during this phase. Myogenin (MyoG) levels substantially increase 
during differentiation 18. MyoG is key in transcribing factors associated with proliferation 
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inhibition (i.e. cyclin-inhibiting proteins), and allows for myoblast differentiation. MRF4, or 
herculin, is also upregulated during differentiation, and is key in myoblast fusion and myofibre 
maturation 19. 
 
1.4 Exercise induced skeletal muscle damage 
Immediately following traumatic SkM injury, pain and swelling help to immobilise the injured 
area. In a milder and more diffuse damage, such as that seen with exercise-induced muscle 
damage (EIMD), range of motion is limited by tenderness experienced with movement. The 
lack of movement allows for regeneration to be prioritised over contractions. 
Many models of SkM regeneration have been developed using animal studies eg. crush injuries 
20 and cardiotoxin-induced muscle damage 21. However, most cannot ethically be upscaled to 
human models. It is possible to analyse regeneration in the context of naturally occurring 
human muscle injury (eg. in sport or work-related injuries), but this is logistically very 
unpredictable and a consistent injury cannot be expected. Similarly, myopathies may be 
harnessed to analyse regeneration. However, an afflicted tissue is used, and the chronic nature 
 
Figure 1.2. Schematic of satellite cell activation, proliferation and differentiation, with the corresponding 
myogenic regulatory factors involved. 
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of this affliction does not mimic acute injury. One method that does allow for the analysis of the 
full spectra of moderate muscle damage in heathy human subjects in vivo is exercise-induced 
muscle damage (EIMD). SkM is an important tissue for in vivo research in its ability to be 
voluntarily recruited for work, a characteristic distinguishing it from smooth muscle. It can 
therefore be manually manipulated through exercise, allowing experimentation within the 
context of normal physiology. 
Three types of muscle contractions exist; isometric, concentric and eccentric. These manifest as 
no change in muscle length, muscle shortening and muscle lengthening, respectively. Eccentric 
contractions add significantly more strain to a muscle than the concentric contractions that 
predominate daily activity 22. This is a result of the fewer motor units recruited, intensifying the 
strain on each fibre. Muscle damage from unaccustomed or excessive eccentric contractions in 
laboratory protocols manifests much like the classic delayed onset muscle soreness (DOMS) 
sometimes experienced 24-48 hours after somewhat intense eccentrically-biased exercise 
undertaken in daily life (eg. walking down a flight of stairs, or slowly putting down a heavy 
object). The extent of damage can then be assessed by a combination of strategies. Direct 
assessment involves muscle biopsy and visualisation of sarcomere ultrastructure changes with 
microscopy 23. Indirect assessment of muscle damage includes assessment of perceived muscle 
soreness 10 and the analysis of isometric force output 22. Eccentric exercise protocols, such as 
downhill running and plyometric jumping, have been shown to successfully induce transient 
muscle damage in humans 10 12 13 24. 
Of importance for this thesis is the ample evidence that eccentrically-biased protocols cause 
changes in circulating damage and inflammatory markers (typically creatine kinase and 
interleukin-6, respectively) 14 25. However, changes in these markers are variable and do not 
reflect the extent of damage, but simply that EIMD has occurred. The identification of alternate 
circulating biomarkers of EIMD have been pursued, particularly involving the cytokine families 
eg.  Il-8 26 and IL-10 27. However, these markers originate from injured muscle cells, uninjured 
exercising muscle and immune cells 28. Therefore, there are still no stringently validated 
biomarkers of skeletal muscle damage, and new options are continuously being sought., 
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particularly amongst circulating factors that are easily accessible by blood sampling (for a recent 
review see Rebalka and Hawke, 2014 29).  
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Chapter 2: Extracellular vesicles 
 
2.1 Introduction to extracellular vesicles 
Over the past decade, a novel form of intercellular communication has emerged: Extracellular 
vesicles (EVs) are nano-scale, stable and selective mediators of cellular information transfer 30. 
They are comprised of a spherical, cell-like lipid bilayer that affords the protection of the 
macromolecules that are their cargo (i.e. lipids, proteins and nucleotides). They are found in 
biofluids such as blood, urine and saliva 31. EVs are categorised into small 30-150 nm 
(exosomes), medium 100-1000 nm (microvesicles), and large 1 µm and greater (most typically 
apoptotic bodies), and have been found to be secreted by almost all cell types 30. Apoptotic 
bodies are important mediators of cell death.  In contrast, exosomes and microvesicles deliver 
cargo between cells and therefore may play a more functional role  32 33 34. In much of the peer-
reviewed literature, exosomes and microvesicles are collectively termed exosomes. However, it 
is more correct to use the term vesicles, in particular, “extracellular vesicles (EVs)” in 
accordance with guidelines set by the International Society of Extracellular Vesicles (ISEV) 35. 
2.2 The emergence of EV biology 
The presence of EVs was first established in blood research, by Chargaff and West in 1946 36. In 
trying to better understand the mechanisms of blood clotting, these researchers noted a protein 
pellet in human plasma following high speed centrifugation (i.e. 31 000 g). When supplemented 
onto plasma taken from a patient with hemophilia (i.e. blood void of clotting factors), blood 
coagulation was noted. In 1967, Peter Wolf made use of transmission electron microscopy to 
visualise intact particles in similar plasma pellets 37. He termed these spherical particles, 
“platelet dust”, but did not identify their vesicular nature. Just over two decades later, Pan et al  
monitored the fate of immuno-gold labelled transferrin receptors during experiments aimed at 
elucidating the maturation of reticulocytes 38. At that time, it was known that transferrin 
receptors were only present in immature reticulocytes. These researchers noted “selective 
externalisation of the antibody-receptor complex”, and concluded that the necessary extrusion 
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of the receptor during reticulocyte maturation was facilitated by vesicle secretion. “Platelet 
dust” was then retrospectively also seen to be vesicular in nature. Together, these studies 
established the presence of vesicles in blood, some of which at least were also functional.  
In a pioneering study by Raposo et al, EVs were revealed to confer antigen-presenting 
information between immune cells in vitro 39. These researchers supplemented EVs derived 
from antigen-exposed B cells onto T-cells, and recognised the mediation of antigen information 
through MHC class 2 integration into EVs. This study established the role of EVs in the transfer 
of immune competency between cell types, helping to establish their roles as functional 
mediators of intercellular communication. A decade later, Ratajczak et al noted the presence of 
mRNA transcripts in EVs 40. Furthermore, this group found that some mRNA transcripts were 
enriched in EVs when compared to their expression levels in parent cells. However, it was not 
until a pivotal study by Valadi et al a year later, that EV biology really began to emerge 41. Using 
radio-labelled nucleotides, this Swedish research group showed that EVs not only encapsulate 
RNA, but deliver RNA species between cells. Astoundingly, this transferred RNA remained 
functional, and was transcribed in the recipient cell. These findings have greatly propagated 
research into EV biology. 
2.3 EV biogenesis, release and uptake 
2.3.1 Biogenesis 
Both types of EVs originate from the plasma membrane. Larger microvesicles (100-1000 nm) 
bud directly from the cell membrane in a blebbing-like process. Smaller exosomes (30-150 nm) 
form through endocytosis of the cell membrane into an early endosome. Maturation of this 
early endosome involves repeated steps of inward budding/pinocytosis, resulting in a 
multivesicular body (MVB) containing many intraluminal vesicles (ILVs) 42 (Figure 2.1). Upon 
stimulation, the membrane of MVBs fuse with the plasma membrane of the parent cell, and 
ILVs are released into the extracellular space. Once exocytosed, ILVs are then termed exosomes. 
A focus will be placed on exosome biogenesis in this thesis. 
 




Figure 2.1. Diagram of extracellular vesicle biogenesis and release. 
 
The best described pathway for exosome formation involves a family of ± 20 proteins, 
collectively termed the endosomal sorting complex required for transport (ESCRT) (Figure 2.1) 
43. The ESCRT family forms four complexes that, along with associated proteins, are widely 
considered key in the coordination of MVB formation and ILV packaging 43. ESCRT-0 proteins 
incorporate ubiquitin-tagged membrane proteins into exosomes, through the actions of the 
proteins; HGS (hepatocyte growth factor-regulated tyrosine kinase substrate) and STAM (signal 
transducing adaptor molecule) 44. ESCRT-1 & 2 are responsible for bud formation and cargo 
packaging of ILVs, occurring during maturation of an early endosome into a MVB. This process 
is aided by the commonly identified EV-enriched proteins; TSG101 (tumour suppressor gene 
101) and ALIX (programmed cell death interacting protein 6) 43. ESCRT-3 proteins are 
responsible for the excision of the bud, allowing for isolation of ILVs from the cytosol of the 
parent cell 43. It is important to note that the exact mechanisms of cargo selection and 
recruitment to the ILVs are yet to be established. Given this, the ESCRT family cannot be taken 
as the complete description for exosome formation. For example, MVBs have been shown to 
form in the absence of some ESCRT proteins 45. Non-ubiquitinated proteins have been shown to 
Stellenbosch University  https://scholar.sun.ac.za
4 
 
be packaged into ILVs, suggesting that packaging may occur through unlabeled-protein, or 
non-ESCRT-0 related, mechanisms 46. A candidate for directing cargo to ILVs is heat shock 
protein 70 (HSP70), an established protein chaperone in physiological processes like autophagy 
47. Interestingly, this protein is enriched in EVs and is now proposed as a vital mediator of 
selective cargo packaging into EVs 48 49.  
Taken together, these studies suggest that exosome biogenesis is complex. Although the key 
players in the synchronization of vesicle formation remain to be precisely elucidated, advances 
in EV analysis are piecing together the fragmented picture at a rapid rate. 
2.3.2 Release 
Studies using electron microscopy have captured sequences of images suggesting that exosome 
release into the extracellular space occurs through fusion of MVBs with the parent cell plasma 
membrane 39 42. Interestingly, not all MVBs are directed toward the plasma membrane. Distinct 
subpopulations are apparent. MVBs are either directed toward lysosomes for degradation, or to 
the plasma membrane for exocytosis of their ILVs. In reticulocytes, MVBs positive for Rab5, an 
early endosome marker, are directed to the plasma membrane 50. Five additional members of 
the Rab family of proteins; Rab 2b, 5a, 9a, 27a and 27b have also been implicated in regulation of 
exosome release 51, thereby highlighting the important role of the Rab family in exosome 
release. In contrast, the presence of some classical endosomal proteins, such as LBPA, are 
known to direct MVBs toward lysosomes 48. Therefore, the protein composition of MVBs 
appears to regulate their fate.  The lipid content also seemingly plays a key role in MVB 
trafficking through the cytosol, as cholesterol-enriched MVBs preferentially fuse with the 
plasma membrane 52.   
Although some biomolecular profiles, as mentioned above, have been correlated with exosome 
release, the stimuli for release are not well-established. The extent of exosome release in vitro 
has been reported to be affected by an array of different stimuli. For example, diverse 
molecules, such as calcium 53, potassium 54 and ATP 55 have been shown to affect the quantity of 
exosome release into media. These early studies show a small fraction of the diverse stimuli that 
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have since been shown to alter exosome release (for a recent review see Colombo et al, 2014 43). 
However, much less is known about exosome uptake. 
2.3.3 Uptake 
Generally, EV uptake occurs through one of three mechanisms following a receptor-ligand type 
interaction. An EV can either fuse with the recipient cell membrane to release its cargo into the 
recipient cell 56, be engulfed (intact) and directed to cell compartments 57 58, or potentially not 
release its cargo but behave more like a ligand resulting in a classic receptor-ligand intracellular 
signaling cascade 59. 
Internalization of intact EVs has been described through the mechanisms of; polymerization-
dependent phagocytosis by macrophages 60, receptor-mediated endocytosis 57 and lipid-raft 
dependent fusion 61 to name but a few. An example of EVs, or their cargo, not internalised by 
the recipient cell was shown in a study by Denzer et al 62. These researchers isolated EVs from 
antigen-presenting cells, and noted that internalization was not necessary for transference of 
immune competency.  
To better understand EV uptake and whether or not it is specific, Alvarez-Erviti et al engineered 
EVs to present a surface receptor containing an amino acid sequence that would be recognised 
by receptors specifically expressed on either neuronal or muscle cells 63.  The engineered EVs 
bound only to the cells of the neuron or muscle cell line, to which their surface receptor 
sequence had been targeted. This implies that EV uptake is most likely highly specific, at least 
some of the time. 
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2.4 EV Cargo 
2.4.1 Lipids 
EVs are comprised of a lipid bilayer, with the orientation resembling that of their parent cells. 
Regarding the structure and content of EVs, their lipid bilayer and possible lipid cargo have 
received the least attention to date (Figure 2.2). Nonetheless, differences between EV 
membranes and parent cell membranes is rapidly becoming apparent.  
Cholesterol, phosphatidylserine and sphingomyelin have been found to be particularly 
abundant in EV membranes when compared to the plasma membrane from which they were 
derived 64. Collectively, these lipids manifest in tightly-packed, organised, and lipid-dense 
regions of the EV membrane, known as lipid rafts 65. The existence of lipid rafts on EV 
membranes is substantiated by the presence of the lipid raft-associated protein, flotillin-1 66, 
which is also characterised as one of the EV-enriched proteins. Lipid rafts are widely considered 
essential to the stability of EVs within biofluids, as their constituent lipids are known to provide 
rigidity 66. However, whether these lipid rafts are formed at the early endosome, or are 
endocytosed from the parent cell membrane, is yet to be established. However, as biomarkers, 
EV membrane profiles may emerge as important.  
Recently, a difference in lipid profile between urine-derived EVs (healthy individuals) and 
cancer cell media-derived EVs has been shown 32, with cholesterol levels higher in the former. 
This further supports the hypothesis that circulating EVs display a lipid profile that allows for 
their stability within biofluids. The lipid profile of EVs has received significant attention from 
cancer researchers 32 33. Cancer cells likely exhibit a different lipid profile to aid their survival in 
hypoxic, elevated ROS and acidic environments. The release of EVs from damaged tissue may, 
therefore, likely also be different to basal EVs in circulation of healthy individuals. 
Lipids are not only responsible for the structure of EVs, but can also play a role in 
communication between cells since EVs contain lipids intra-luminally. Subra et al showed the 
capacity for EVs to transfer a physiologically-relevant concentration of prostaglandins into the 
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cytosol of recipient cells in vitro 67. This study, like others, highlights the role of EVs as a 
functional unit of intercellular communication. 
 
 
Figure 2.2. Number of published EV papers focusing on proteins, RNA or lipids as structural elements 
or cargo published from 2005-2015. Data was taken from PubMed, using an advanced search for 
“extracellular vesicles” OR “exosomes” OR “microvesicles” AND “protein”/ “RNA” or “lipid”. 
 
2.4.2 Protein 
Proteins are not only part of the EV cargo, but also established components embedded in the 
lipid bilayer. Three members of the tetraspanin family of transmembrane proteins, CD9, CD63 
and CD81, are some of the most commonly identified EV-enriched proteins, as per the online 
EV database, ExoCarta (ExoCarta.org). Not surprisingly, the ESCRT family proteins are also 
enriched in EV isolates. It is important to note that the abundance of EV-enriched proteins is 
altered between differing physiological conditions and cell/organism types 35, and a consistent 
profile has not been established. This may be why no definitive protein has been identified as 
an exclusive EV marker. Nonetheless, attempts have been made to promote ESCRT-associated 
proteins, i.e. TSG101 and Alix, as appropriate identifiers 35.  
Advances in mass spectrometry have aided the identification of a vast number of proteins in 
EVs. A wide variety of proteins have been found eg. transcription factors, cytokines, receptors 
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and growth factors 48 68 69. Furthermore, a diversity in the EV proteome is also apparent between 
cell types and physiological state. New online databases, such as; EVpedia (evpedia.info), 
ExoCarta (ExoCarta.org) and Vesiclepedia (microvesicles.org), have been established to sort and 
with more time to standardise the large amount of data currently being generated on EV 
proteins.  
 
2.4.2.1 EV-enriched proteins are used for quality control of EV isolation 
In 2014, ISEV has proposed a set of minimal experimental requirements to determine the 
existence of EVs in an isolate 70. In this position paper, it was proposed that both positive and 
negative protein markers should be employed to ascertain the presence and purity of EVs. The 
presence of EVs should be established through the detection of at least two proposed protein 
groups (See Table 2.1). 
The presence of EV-enriched membrane proteins (both transmembrane and membrane-
associated) is required to define the correct isolation of EVs (Table 2.1 A & B). Characterization 
of EV-related proteins is convoluted by the frequent co-isolation of contaminating proteins 
(Table 2.1 D). The reason for this contamination is not well understood, but is hypothesised to 
result from molecules of similar density or aggregation mechanisms. Furthermore, given the 
physiologically relevant mediation of communication by EVs, as opposed to the random 
incorporation of cellular components in ABs during cell death, the presence of organelle 
structural proteins is used as a negative control. 
 




As mentioned before, the presence of EV RNAs was first discovered in 2006 40. In 2007, Valadi et 
al using microarray profiling of the RNAs and identified the presence of over 1300 different 
mRNAs, and 120 different microRNAs in EVs isolated from a mast cell line (MC/9). In the same 
paper these authors reported the mRNA and microRNA content in EVs in comparison to that of 
the parent cells and revealed an enrichment of particular RNAs in EVs. Furthermore, they 
reported the capacity of EVs to transfer RNA to recipient cells. This study raised so many 
intriguing questions that it is considered instrumental in the propagation of the EV research 
field (see consistent increase in EV RNA studies in Figure 2.2).  
Messenger RNA (mRNA) forms the intermediate phase in the central understanding of 
molecular biology, whereby DNA is transcribed into RNA, which is subsequently translated 
into proteins. The transfer of mRNA in EVs provides a unique opportunity for protein to be 
translated in a separate cell/tissue from that in which it was initially transcribed. However, 
RNAs found in EVs are predominantly smaller than mRNA transcripts. Indeed, EVs are known 
to be enriched in microRNA and 3' untranslated region (UTR) mRNA fragments. Other small 
RNAs such as piwi-interacting RNA, tRNA, rRNA, yRNA and non-coding RNA have also been 
detected 71. Of these, perhaps the most interesting is microRNA. 
2.4.3.1 microRNA 
microRNAs (miRs) are ± 22 nucleotide, single-stranded sequences responsible for post-





C. Not expected 




Alix3 ER (Calnexin) Albumin 
CAMs TSG10111 Nuclear HDL & LDL 
Flotillin41 HSP702 Golgi (organelle) Immunoglobulins 
 
Table 2.1. Four groups of proteins proposed by ISEV, to define the presence of EVs in an isolate. Top 
identified proteins are denoted by a superscript corresponding to their position on the top 100 most 
identified proteins list (ExoCarta v.3.2). 
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downstream effects on many cellular functions. In humans, miRs exert their effects through the 
transient repression of messenger RNA (mRNA) translation. This is accomplished by 
incomplete binding of a miR to an mRNA transcript, preventing translation of the mRNA into 
protein. This incomplete binding chiefly occurs at the 3’ UTR of the mRNA 72, and allows miRs 
to target approximately 60% of the human genome. According to version 21 of miRBase (an 
online database for miRs run by the Sanger Institute), over 2500 human miRs have been 
identified. (See Appendix 1 for further detail on miR biogenesis and nomenclature). 
From a functional point of view, it is now well known that one mRNA can be targeted by more 
than one miR, and it is possible for one miR to bind one mRNA at multiple sites. Furthermore, 
particular miRs can target multiple different mRNAs. This convolution of information has made 
the narrowing down of specific miR functions challenging, but in no way lessens their potential 
importance.  
One might consider that the research fields of miRs and EVs are both still in their infancy, and 
the potential of both may allow these fields to progress in parallel.  In the next chapter, key 
studies addressing the effects of EVs in vitro, as well as the origin of circulating EVs in vivo will 
be reviewed. Lastly, the next chapter will review the current understanding of EVs in the 
context of SkM. 
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Chapter 3: Key extracellular vesicle 
studies 
 
3.1 Effects of EVs on cells 
Specific cellular and physiological effects of EVs have been described in many fields. Perhaps 
the best described effects have been shown in the context of stem cell research. The 
supplementation of stem cell-derived EVs onto unipotent cell types, and vice versa, allowed 
researchers to gain an understanding of cell programming, reprogramming and dynamics that 
could become beneficial for regenerative medicine. Three examples of such studies will be 
presented below.  
The supplementation of primary monocytes-derived EVs onto mesenchymal stem cells (MSCs) 
in vitro (i.e. two key cell types involved in tissue regeneration), has helped illuminate the role of 
EVs in deciding stem cell fate 73. The researchers at the University of Gothenburg, Sweden 
showed that this EV addition propagated an osteogenic gene profile in MSCs. More specifically, 
they found the presence of osteogenic transcription factors in EVs, but not in the media 
suggesting that direct transfer was involved. Sahoo et al went a step further and found that 
CD34-derived EVs could enhance angiogenesis both in vitro in an endothelial cell culture and in 
vivo in mouse corneas 74. In relation to skeletal muscle, a landmark study was done by Hu et al 
an in vivo mouse hind-limb ischemia/reperfusion model. The authors deduced that MSC-
derived EVs perfused into the injury site lead to changes associated with enhanced healing, 
including increased blood flow to the injured area and an increase in the angiogenic molecular 
profile of the tissue. Possible mechanisms were elucidated in vitro, where increases in human 
umbilical-derived vascular endothelial cell (HUVEC) migration, proliferation and tube 
formation were found 75.  
Such studies highlight the potent influences EVs can have at the cellular level as well as the 
potential of EVs as therapeutic agents. Their ability to carry cell/tissue-state specific information 
avoids critical fall-throughs encountered with other cell therapy modalities, such as the lack of 
Stellenbosch University  https://scholar.sun.ac.za
12 
 
stem cell adherence to injured sites in stem cell injection studies and the seeming avoidance of 
an immune response in the recipient. Recently, the revelation of EV signatures that correlate to 
physiological states 33, has brought to light other promising applications of basic and applied EV 
research to the clinical setting. 
 
3.2 Effect of physiology on EVs: state-specific and tissue-specific EVs 
At present, a large proportion of EV research is directed toward identifying circulating EV 
profiles (i.e. of protein, RNAs or lipids), that may help negate the use of invasive tissue biopsies 
for diagnosis. The use of EVs as a less invasive “liquid biopsy”, may facilitate early diagnosis of 
diseases if ‘signatures’ can be confirmed and may facilitate the monitoring of treatment 
interventions in a more sensitive and immediate manner. 
Specifically, much current EV research is directed toward understanding tumour environments 
and tumour metastasis. Moreover, research into cancer diagnosis is now looking toward 
circulating EVs to determine the presence of cancers that would otherwise be too difficult to 
reach for biopsy. A recent revolution in EV biology saw a significant correlation between an EV-
enriched membrane-associated protein, glypican-1 (GPC1), and pancreatic cancer in humans 33. 
GPC1 increased in EVs isolated from patients’ serum throughout the time course of tumour 
enlargement and stage development. These researchers found that this state-specific correlation 
was sensitive enough to discriminate between benign and cancerous tumors. In another recent 
study, Skotland et al made use of mass spectrometry to identify nine lipids from urinary EVs that 
showed significantly different expression between prostate cancer patients and healthy controls 
32.  Additionally, 8 miRs (out of a selected panel of 43) were found to be decreased in EpCAM+ 
(epithelial cell adhesion molecule) immuno-captured EVs derived from the plasma of patients 
with colorectal cancer 76. 
However, the milieu of circulating EVs is very complicated. Some research groups have 
directed their attention towards the identification of tissue-specific markers on circulating EVs, 
attempting to delineate the tissue of origin of EVs. Guescini et al determined the existence of the 
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muscle-specific protein, alpha-sarcoglycan (SGCA), on the membrane of a portion of human 
plasma-derived EVs 34. Using flow cytometry, they determined that 1-5 % of their sample was 
positive for SGCA, and that 60-65% of this subset was also positive for the EV-enriched protein, 
CD81. This study showed that more detailed profiling of tissue specific EV groups is possible 
and more research along these lines is likely in the future. The complexity of plasma-derived 
EVs may soon be simplified through compartmentalizing EVs harvested from the circulation by 
analysis of tissue of origin. 
 
3.3 EVs and Skeletal muscle 
Only a hand full of studies have investigated EVs in the context of SkM. Although the lesser 
number of these contribute to our current understanding of circulating EVs in vivo, the in vitro 
studies have contributed a great deal to the general method development in terms of EV 
isolation and analysis from blood. Here, these in vitro studies will be dealt with chronologically 
to illustrate the progression in EV analysis regarding SkM. For a direct comparison of details 
between the following 4 key studies, see Table 3.1.   
The first identification of SkM cells releasing EVs occurred less than a decade ago in a study 
using the immortalised mouse myoblast cell line, C2C12s 77. Highlights of this study included 
the comprehensive analysis of the EVs isolated from the media. This analysis included both 
positive identification of typical EV enriched proteins and visualisation using TEM. Of 
importance for theoretical aspects of muscle research was the identification of peptides and 
proteins, DNA and mitochondrial DNA that revealed the cargo contained some structural 
proteins, mitochondrial proteins, several heat shock proteins and even smaller proteins (i.e. low 
kDa) with the common characteristic of being able to influence cell signaling (e.g small GTP-
binding protein, Rab7). In 2012, a relatively similar study was performed using primary human 
myoblasts (PHMs) 78. This study used many of the same EV isolation techniques, but expanded 
on the first study mainly by separating the analysis of microvesicles and exosomes. Only 35% of 
the cargo was common to both types of vesicles. Eighteen % of the proteins identified were 
exclusively present in exosomes, whereas 47% were exclusively present in microvesicles. 
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Therefore, it became apparent that the consideration of vesicle size is of utmost importance in 
interpreting vesicle-mediated communication. Also, using a combination of proteomic and 
bioinformatic strategies, Le Bihan et al found that differentiating PHM-derived EVs contained a 
more diverse protein profile than expected. The presence of many proteins not considered to be 
involved in myogenesis led them to the hypothesis that myoblast-derived EVs may be 
important in intercellular communication between different cell types. Futhermore, two years 
later, Forterre et al elucidated large differences in EVs protein cargos when comparing myoblast 
states i.e. proliferating myoblast-derived EVs contained 31 proteins not found in myotube-
derived EVs 79. This suggested that EVs could also be important communicators during 
different stages of muscle damage and regeneration. Eventually, in that same year it was shown 
that EVs from differentiating C2C12 cells could aid neural cell survival and neurite outgrowth 
of the motor neuron cell line, NSC-34 80. This study was also the first to report the 
characterisation of SkM EVs using a technology called nanoparticle tracking analysis (NTA). 
This was significant as it allowed for the quantification of a heterogenous (according to size) 
pool of EVs based on size and number. This technology was to become important in future 
studies of EVs harvested from blood samples. 
Author/ year Model EV isolation EV analysis 
Guescini et al, 2010 77 C2C12 (prolif) 
24 hr 
DC + sucrose gradient 
WB, TEM, MS & PCR 
Le Bihan et al, 2012 78 PHM (diff) 
24, 48 & 72 hr 
DC + iodixanol gradient 
WB, TEM, MS, Luminex 
profiling, RNA 
microarray & CM 
Forterre et al, 2014 79 C2C12 (diff) 
48 hr 
DC 
WB, TEM (+ gold), 
NanoSight, qRT-PCR, 
MS, transfection & FM 
Madison et al, 2014 80 
C2C12 (diff) & 
NSC-34 (diff) 
48 & 96 hr 
DC 
 
WB, NanoSight & FM, 
Table 3.1. Chronological detailing of studies analysing EVs in the context of SkM in vitro. (PHM = primary human 
myoblasts, diff = differentiating, prolif = proliferating, DC = differential centrifugation, WB = western blotting, TEM = 
transmission electron microscopy, MS = mass spectrometry, FM = fluorescence microscopy, CM = confocal microscopy).  
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3.3.1 EVs and skeletal muscle regeneration 
Briefly mentioned before, mesenchymal stem cells (MSCs) are multipotent cells with key roles 
in the regeneration of many tissue types. Recently, a comprehensive study on MSC-derived EVs 
and SkM regeneration was published by Nakamura et al 81. These researchers elaborated on the 
paracrine effects of MSCs by showing that their EVs could promote myogenesis and 
angiogenesis in C2C12 and HUVEC cells, respectively. These same effects were confirmed on 
skeletal muscle in vivo, where EVs were injected into the site of injury in a mouse model of 
cardiotoxin-induced muscle injury. This study, alongside the previously mentioned study of Hu 
et al 75 on hind-limb ischemia-reperfusion damage were the first to investigate muscle 
regeneration, as opposed to behavior of a cell line. Both are providing impetus for more in vivo 
experimentation.  
EVs derived from differentiating PHMs can also confer a myogenic profile (eg. increased 
expression of MyoD and increased cell fusion) to human adipose-derived stem cells 82. These 
researchers found a reduced fibrotic area in vivo, following injection of EVs into lacerated mouse 
skeletal muscle. Although the research described so far is very illuminating, it was limited to 
animal models. 
3.3.2 EVs and exercise 
Very few studies have investigated the nature of EVs in the context of exercise: only 3 studies 
can be reported here.  
Following an acute bout of aerobic exercise (50 minutes at 60-70 % of VO2peak), microvesicles 
were isolated from plasma derived from 8 ml blood samples 83. These authors did not identify 
EVs using any of the markers discussed above, but relied solely on size calibrated flow 
cytometry isolating particles < 1 µm in diameter (i.e. within the microvesicle range) that were 
also positively stained for one or more of the endothelial proteins CD34 and/or CD62E. Using 
only these cell surface markers it was not possible for the authors to make any pronouncements 
on the effects of exercise on microvesicle or exosome release. However, their objective was to 
investigate the endothelial marker enrichment and they found gender-based differences:  CD34+ 
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EVs and CD62E+ EVs were elevated to different extents immediately post-exercise when 
comparing males and females, respectively. A generalised conclusion from this study could be 
that exercise may affect vesicle composition.  
Fruhbeis et al 84 showed that the EV number in plasma increases immediately after an acute bout 
of aerobic exercise (incremental cycling or running to fatigue), returning to baseline numbers at 
90 mins post-exercise. Although 12 subjects were recruited for this study, all of whom exercised 
at least 3 hours per week, 8 performed the cycling test and only 4 performed the running test. 
Although not explained, one might presume this was due to their habitual exercise choice. In 
keeping with the evolution of EV analysis techniques in the cell studies, these authors used 
NTA technology along with western blotting to characterise EVs isolated by ultracentrifugation. 
However, in-depth EV cargo analysis was not done in this study. It should also be noted that 
comprehensive analysis was not done for all subjects i.e. for each exercise discipline two 
subjects’ EVs were analysed using NTA, whereas 6 (cycling) and 4 (running) were analysed 
only by western blotting. Nonetheless, this was the first study to report increased EV release up 
to 2-fold immediately post-exercise.  Blotting for TSG101 did not reveal a similar increase in 
band density to what may have been expected based on the NTA results. Taken together these 
data suggest that exercise is a significant stimulus for EV release, but more studies are required 
to better identify EVs in this context convincingly.  
Taking a different approach, Guescini et al related resting EVs to aerobic fitness rather than 
investigating an acute effect of exercise on EV mobilization 34. EVs were identified as originating 
from muscle by positivity for SGCA. Furthermore, they showed that SGCA+ immuno-captured 
EVs were enriched in miR-206, which as mentioned earlier is a myomiR and hence confirmed 
muscle as their tissue of origin. They also showed that baseline plasma levels of myomiR-1, 
myomiR-133b and myomiR-206 in EVs were statistically significantly and positively correlated 
to VO2 max, a measure of aerobic fitness. To our knowledge, this is the only study that has 
measured myomiRs packaged in EVs from human subjects, although several reviews now 
promote the notion of EV and myomiRs as circulating communicators of SkM 85 86 87.  
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3.3.3 EVs and myomiRs 
Skeletal muscle exhibits a distinct enrichment in microRNAs that suggests tissue-critical roles. 
The term “myomiR” has been used to describe the family of miRs with key roles in both cardiac 
and skeletal muscle regulation 88. A good example of this is shown in myostatin null mice, who 
show an increased expression of all canonical myomiRs in skeletal muscle lysates 89. Four 
archetypal myomiRs, working in close conjunction with the MRFs, have been shown to be of 
particular importance; miR-1, 206, 133a and 133b 90. MyomiRs are detected in muscle lysates, as 
well as in blood, and their expression is altered during different physiological states 91 92. The 
potential of myomiRs as a key component of SkM understanding is highlighted by the surge in 
research trying to detect circulating myomiR profiles that could serve as biomarkers for 
myopathies 93 94 95. 
In addition to being possible biomarkers, the functional effects of the myomiRs that form part of 
EV cargo must be considered. miR-1 and miR-206 are involved in promoting myoblast 
differentiation, whereas miR-133a and miR-133b are seemingly involved in promoting 
proliferation 90. However, the exact roles of miR-133a and miR-133b remain unclear. Of the 
myomiRs, miR-1 expression is often reported to exhibit the largest changes in response to 
stimuli 96 97. In as early as 2005, the importance of miR-1 was revealed in its ability to produce a 
myogenic profile when transfected into HELA cells 72.  
Further than just enrichment, some miRs are considered tissue-specific. These are defined as 
existing in twenty-fold greater abundance in a particular tissue when compared to their average 
in other tissues 98. Of the myomiRs, miR-206 is the only established SkM-specific miR 98.Other 
myomiRs occur in cardiac and smooth muscle cells/tissue. Tissue-specificity suggests a tissue-
specific function.  In miR-206 knockout studies, no overt change in myoblast phenotype was 
noted in vitro 99. However, a delay in the regenerative response to cardiotoxin-induced SkM 
injury was seen in vivo 21. Interestingly, MyoD and myostatin are both transcriptional activators 
of miR-206 100 101. Much like the MRF protein, MyoD, miR-206 is considered pivotal in SkM, and 
its expression is increased throughout myoblast differentiation 102 103. Indeed, miR-206 is known 
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to repress the expression of Paired box transcription factor 7 (Pax7), a protein that aids SC 
quiescence, thereby allowing SC activation and differentiation 104. 
Another important miR in myoblast regulation is miR-31. Although not classified as a myomiR, 
miR-31 has been shown to bind Myf5 at the transcript level, contributing to the maintenance of 
SC quiescence 17. Interestingly, miR-31 is also known to target dystrophin mRNA, and its 
expression is greatly elevated in muscle biopsies from Duchenne muscular dystrophy patients 
105. 
In the context of exercise, Banzet et al shown that myomiRs are not significantly affected by 
concentrically-biased exercise. In contrast, miR-1, 133a and 133b are elevated within 6 hr 
following eccentrically-biased exercise 91. Recently, Coenen-Stass et al found no changes in 
circulating myomiR levels in mice for the subsequent 7 days following a 20 min aerobic exercise 
regimen 106. In vitro, however, they noted a large and consistent increase in miR-133a and miR-
206 in the media of PHM switched to differentiation for nine days, with no change in miR-31 
noted. Importantly, both these studies considered total circulating miRs in their analyses, rather 
than miRs specifically packaged in EVs. It is clear that more detailed information is needed on 
myomiRs to fully elucidate their roles in SkM. 
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Aims and objectives 
 
Following review of the literature, the hypothesis formulated for this thesis was that: 
“Exercise-induced muscle damage causes substantial changes in  
circulating extracellular vesicles” 
 
To address this hypothesis this thesis aimed:  
“To determine whether circulating exosome size, number and cargo is altered in response to 
exercise-induced muscle damage from an acute bout of eccentrically-biased exercise.” 
 
Specific Objectives:  
1. To use a combination of two eccentrically-biased exercise protocols to produce EIMD. 
2. To quantify the number and sizes of exosomes pre and post EIMD. 
3. To analyse selected protein content of exosomes pre and post EIMD using two techniques:  
a. Tetraspanin CD9 immunogold labeling with TEM visualisation. 
b. Global qualitative assessment of protein with Coomassie gel staining. 
4. To analyse the expression of select miRs in exosomes, in response to an acute bout of EIMD: 
a. myomiR-1, 133a and 133b. 
b. SkM-specific miR-206. 
c. miR-31 (known to be involved in regulation of the MRF, Myf5). 
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Chapter 4: Materials and methods 
 
4.1 Ethical considerations 
This study was approved by Stellenbosch University’s Health Research Ethics Committee 
(Study reference: N15/08/075), and was carried out in accordance with the guidelines of the 
South African Medical Research Council. 
4.2 Participants 
n = 9 healthy, untrained males between the age of 18 and 30 volunteered for this study. 
Exclusion criteria for participants included; regular exercise exceeding 2 bouts per week, 
participation in professional sports, or the use of anti-inflammatory medication within 3 months 
preceding the study. Furthermore, participants were required to be in good health (i.e. with no 
chronic illness), and were not to have participated in any strenuous exercise in the 3 weeks 
preceding the study.  
4.3 Eccentric exercise regimen 
Each participant performed an acute bout of eccentric exercise that consisted of plyometric 
jumping (PMJ) and downhill running (DHR). The protocol was modified from two similar 
protocols previously used in our lab 13 23. The combined exercise protocol was chosen due to 
prior results indicating that PMJ targets almost exclusively the fast twitch fibres, whereas 
running recruits both fibre types 13 23. Hence, it was hypothesised that combining the two 
protocols would resultant in more diffuse muscle damage. Both exercise types use the large 
quadriceps muscles and their antagonists, possibly maximising the potential for EV release 
from SkM.   
Briefly, fasted participants arrived at the exercise lab in the morning, and were guided through 
a 5 min warm-up focused to the quadricep muscles. Following this, all participants were 
required to complete 10 sets of 10 plyometric jumps at 90 % of their maximum achievable jump 
height, with a 1 min interval between sets. Upon completion of the PMJ regimen, a 5 min rest 
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period was given before commencement of the DHR regimen. Briefly, participants were 
required to perform 5 sets of 5 min bouts of downhill running at 10 km/ hr, at a 10 % decline 
(Figure 4.1), and a 2 min standing interval between sets. 
 
Figure 4.1. Image of participant performing the downhill running regimen. The rear end of the 
treadmill was elevated to achieve an angle of 10 % decline. 
 
4.4 Perceived muscle soreness and blood sampling 
Following the DHR regimen, whole blood was drawn from the antecubital vein before exercise 
(i.e. baseline), and at 2 hr and 24 hr post-exercise by a certified phlebotomist. On completion of 
the exercise regimen, participants were given a standard meal replacement shake and requested 
not to eat until they returned for the 2 hr blood draw. Participants arrived for the exercise 
intervention fasted, and the shake was given to standardize a post-exercise meal. Participants 
were requested to not take part in strenuous activity until they returned the next day for the 24 
hr blood draw. 
Plasma was isolated from whole blood for subsequent EV isolation. Briefly, whole blood was 
collected into EDTA-coated tubes and centrifuged at 1200 g for 10 mins at 4° C. Plasma was 
aliquoted and immediately frozen at - 80° C. Additionally, another aliquot of whole blood was 
collected into heparin-coated tubes for serum creatine kinase analysis (analysis by PathCare, 
South Africa). In this analysis, the change in absorption of UV light, caused by a reaction 
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coupled to NADH production, is read by a microplate reader. At 2, 24 and 48 hr post-exercise, 
participants gave a rating (out of 10) of their perceived muscle soreness upon walking and with 
the application of thumb pressure to the quadriceps muscles. A score of 0 signified no pain, 
with 10 signifying extreme pain. 
 
4.5 EV isolation 
EVs were isolated from plasma using qEV size exclusion columns (iZon Science), according to 
the manufacturer’s protocol (Figure 4.2). The specifications of these columns result in a 
predominantly exosome, rather than microvesicle, isolate. Henceforth, this isolate will be 
termed exosomes. Briefly, plasma was thawed on ice and centrifuged at 15 000 g for 10 mins to 
remove cellular debris. The qEV columns were washed with 5 ml of freshly filtered PBS, and the 
flow rate was determined as a measure of column cleanliness. Subsequently, 1ml of plasma was 
added to the top of the column (Figure 4.2 blue arrow), and multiple 500 µl fractions of the 
resultant elution were collected. qEV columns were continuously topped with PBS, as to not 
allow the filter to run dry. Fractions 7 to 9 were pooled due to their known high vesicle number 
and purity, along with a reasonably low dilution of the exosomes. Samples were aliquoted and 
frozen at -80° C. (See Appendix 3 for a comparison of EV isolation techniques) 
 




Figure 4.2. Image of exosome isolation process with qEV size exclusion columns (iZon Science). 
Purified plasma is loaded above the stationery phase (see blue arrow), following which 
constituents are separated through a Sepharose matrix. 500 µl fractions were collected into 
Eppendorf tubes, and fractions 7-9 were pooled for downstream exosome analysis. 
 
4.6 Transmission Electron Microscopy 
200 mesh, carbon-coated copper TEM grids were glow-discharged, and incubated on 10 µl 
droplets of sample for 5 mins (Figure 4.3). Grids were then washed with dH2O and carefully 
dabbed onto Whatman paper. Following this, grids were incubated on 10 µl of freshly filtered 2 
% uranyl acetate (a negative stain) for contrast. For CD9 labelling of isolated exosomes, grids 
were incubated with mouse, anti-human CD9 primary antibody (1:50, BD Biosciences; 551808) 
for 30 mins, washed, and subsequently incubated with anti-mouse NanoGold (from here on 
termed immune-gold) secondary antibody (1:20, Sigma-Aldrich; G7527) before being stained 
with uranyl acetate. Grids were viewed at 200 kV on a Phillips Tecnai TEM. 
 




Image 4.3. Copper TEM grids are incubated on 10 µl of sample for maximum proximity of grids to 
exosomes. After each step, grids are incubated on distilled water, and carefully dabbed onto 
absorbent Whatman paper as a washing step. 
 
4.7 Gel electrophoresis 
Samples were run on 1.5 mm SDS-PAGE gels with a 12 % resolving gel. A 10-well comb was 
used to enable a maximum loading volume of 66 µl. Gels were electrophoresed at 70 V for 2-3 
hours and detected using the Bio-Rad ChemiDoc imaging system. 
Gels were washed with dH2O, and incubated with Coomassie brilliant blue dye (Sigma-
Aldrich) for 30 mins. Following this, sequential steps of de-staining (30 % Methanol, 10 % Acetic 
acid and 60 % dH2O) was done for 5, 30 and 120 mins. 
4.8 RNA isolation 
Total RNA was isolated from exosomes using the Total Exosome RNA and Protein isolation kit, 
per the manufacturer’s guidelines (ThermoFisher Scientific; 4478545). 600 µl of exosome isolate 
was mixed with denaturing solution in a 1:1 ratio. RNA was isolated by acid-phenol: 
chloroform extraction, using an 11 000 g, 15 mins centrifugation for separation. The resultant 
aqueous phase was removed and diluted 1:1 with 100 % ethanol. 700 µl of the RNA/ Ethanol 
mix was loaded onto glass fibre filter-containing columns and centrifuged at 11 000 g for 15 sec. 
The filtrate was discarded and the column was loaded two more times in order to maximise 
RNA recovery. The RNA-bound column was sequentially washed with two ethanolic solutions 
of differing concentrations, and eluted with a low ionic-strength buffer. Samples were 
immediately frozen at -80° C. 
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4.9 MicroRNA analysis 
Reverse transcription and pre-amplification of microRNA was achieved with the TaqMan 
Advanced miRNA cDNA synthesis kit (ThermoFisher Scientific; A28007). In an initial poly-A 
tailing reaction, 2 µl of total RNA was added to a poly(A) polymerase mix. Next, the product 
underwent ligation with an adaptor sequence. The adaptor ligase activity is dependent upon a 
5’ phosphate, only present on mature microRNAs. In the reverse transcription reaction, the 
poly(A) tail is recognised by an oligo-dt primer that aids the action of a universal reverse 
transcriptase in transcribing the ligated microRNA. Given the low copy numbers of miRs found 
in biofluids, an extra miR amplification step is added with the use of universal forward and 
reverse primers that recognise the adaptor sequence. 
50 µl of the amplified reverse transcription product was diluted in a 1:10 ratio for subsequent 
qPCR analysis. 5 µl of this diluted cDNA was loaded into fast optical 96-well plates, and the 
plates were sealed with optical adhesive film. qPCR analysis was performed in duplicates on a 
StepOne qPCR thermocycler (Applied Biosystems). TaqMan Advanced miRNA assays; miR-1 
(477820_mir), miR-133a (478511_mir), miR-133b (480871_mir), miR-206 (477968_mir) and miR-
31 (478015_mir) were used (all obtained from ThermoFisher Scientific). The full names for these 
miRs are; hsa-miR-1-3p hsa-miR-133a-3p, hsa-miR-133b, hsa-miR-206 and hsa-mir-31-5p, 
respectively. 
Additionally, 1pM of the synthetic C. Elegans oligo, cel-miR-39 (Sequence: 
UCACCGGGUGUAAAUCAGCUUG), was added to the isolated total RNA. This sequence 
does not exist in humans and was used as an exogenous control 107. cel-miR-39 was reverse 
transcribed and amplified with all samples, and all qPCR reactions were normalised to the 
resultant cel-miR-39 Ct values. (See Appendix 2 for a more detailed discussion on this 
microRNA workflow) 
4.10 Nanoparticle Tracking Analysis 
Vesicle size and number were analysed with nanoparticle tracking analysis (NTA), using the 
NanoSight NS500 (Malvern Instruments). Analysis was performed at the Council for Scientific 
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and Industrial Research (CSIR, Pretoria, South Africa). Exosome isolates were diluted in PBS 
(1:200) for a suitable number of particles per frame, and five 30 second videos were used to 
determine particle numbers per ml and mean particle diameter. (See Appendix 5 for more 
information on NTA theory) 
4.11 Statistical analysis 
All data are represented as mean ± standard error of the mean (SEM). Parametric data were 
analysed by means of a two-way ANOVA, with a Fisher LSD post-hoc test. A mixed model 
two-way ANOVA was used for data with unmatched repeated measures. MicroRNA Ct values 
were normalised to an exogenous control by subtracting the sample from the control value. 
Graphs were made using version 5 of GraphPad Prism (GraphPad Software inc, USA), and 
statistical significance was set at a 5 % confidence interval i.e. p < 0.05. 
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Chapter 5: Results 
5.1 Participants 
9 healthy male participants, between the age of 18 and 25, successfully completed the exercise 
protocol. Mean participant height and weight was 179 ± 1.86 cm and 76 ± 4 kg, respectively. 
5.2 Indirect assessment of muscle damage 
5.2.1 Perceived muscle pain (PMP) 
Participants were asked to rate their PMP on a scale of 1-10 (1 = no pain, and 10 = extreme pain). 
Regarding pain in the anterior quadriceps, two indices were measured; PMP upon walking and 
PMP upon palpation. Ratings were obtained at 2, 24 and 48 hr post-exercise. PMP upon walking 
was found to be significantly higher at 24 hr (p < 0.001) and 48 hr (p < 0.05), when compared to 2 
hr post-exercise (Figure 5.1.A). A similar pattern was found for PMP upon palpation of the 
quadriceps, with a significant increase in perceived pain occurring at 24 hr (p < 0.01) and 48 hr 
(p < 0.05), when compared to 2 hr post-exercise (Figure 5.1.B). Both measures displayed a 
plateau between the 24 hr and 48 hr timepoints. The PMP scores observed here are in alignment 
with the timeframe for DOMS manifestation.  
 
  
Figure 5.1. Perceived muscle pain of the anterior quadriceps upon walking (A) and palpation (B). A 
large increase in pain scores is seen for both indices at 24 hr and 48 hr, when compared to 2 hr post-
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5.2.2 Serum creatine kinase (CK) activity 
Serum CK activity, measured in international units/liter (IU/L), is a clinically used indicator of 
muscle damage. To support the findings obtained from PMP scores, serum CK activity was 
measured at baseline (BL), and at 2 hr and 24 hr post-exercise (Figure 5.2). When compared to 
BL, CK activity was significantly elevated at 24 hr post-exercise (p < 0.001). A significant 
difference in CK activity was also observed between 2 hr and 24 hr post-exercise (p < 0.001), 
whereas no change was noted between BL and 2 hr post-exercise. Taken together, PMP and CK 




Figure 5.2. Serum creatine kinase activity before and after the exercise intervention. Values are 
represented in international units (IU) per litre. (Repeated measures ANOVA. Mean ± SEM.  
***p<0.001. n = 9). 
 
5.3 Assessment of the EV Isolation method 
The qEV size exclusion columns (SEC) utilised in this study have previously been used in the 
published literature to isolate exosomes from human plasma 108. To confirm the presence of 
exosomes in the pooled fractions (fractions 7-9) obtained from plasma pre and post exercise, an 
aliquot of the isolated fractions was visualised using TEM. An abundance of vesicles with the 
expected diameter and morphology of exosomes were found to be present (Figure 5.3 A-D). The 
spherical appearance of these vesicles suggests that they were isolated in an intact state, and 
had not been lysed by the isolation process. As expected, qualitative assessment of the TEM 
*** 
*** 
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images suggested that the majority of isolated EVs fell within the exosome size range (30-150 
nm), with vesicles in the microvesicle size range (100-1000 nm) appearing less frequently (see 
Figure 5.3.A arrows pointing to microvesicles). Highly-resolved visualisation of ± 50 nm 




Figure 5.3. TEM images of exosomes at increasing magnifications (A-D). A: a wide-field image 
revealing the abundance of exosomes. EVs within the exosome size range predominate, with 
microvesicles appearing less frequently (yellow arrows). B & C: confirmation of intact vesicle, 
suggesting that they are rendered intact by the isolation process. D: highly resolved images of small 
exosomes. Blurring of the membrane suggests that this size range is approaching the limit of 
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Immuno-gold labelling of pooled exosome fractions was also visualised with TEM. Mouse, anti-
human CD9 primary antibodies, in conjunction with gold-labelled anti-mouse secondary 
antibodies were used. Sufficient contrast to visualise exosomes and 10 nm gold nanoparticles 
simultaneously was achieved with high-resolution brightfield imaging (Figure 5.4). Immuno-
gold labelling was limited to the exosome membrane as would be expected with labelling of the 
transmembrane protein, CD9 (Figure 5.4 yellow arrows). CD9 is a widely-used marker of 
exosomes, and this result therefore further substantiates that the isolation method indeed 
yielded exosomes of high purity. 
5.4 Quantitative exosome analysis with NTA 
To obtain more quantitative data on the numbers and sizes of exosomes obtained using the qEV 
SEC method, samples were subjected to NTA. The pooled fractions were abundant in vesicles 
within the exosome size range (i.e. 30-150 nm). An example of this can be seen by the peaks in 
the representative NTA report graph in Figure 5.5. 
 
Figure 5.4. Highly-resolved TEM image of immuno-gold labelled exosomes. Clearly visible gold 
nanoparticles (± 10 nm, yellow arrows) are seen on the membrane. Antibodies against the exosome-
enriched transmembrane protein, CD9, were used. 




Figure 5.5. Representative graph of particles/ ml vs particle diameter (nm) from a Nanoparticle 
tracking analysis report. The graph represents the mean of 5 runs from one of the 26 samples 
measured. Red error bars denote SEM. (Dilution: 1:200). 
 
Statistical analysis of vesicle number and size indicated no significant differences between 
timepoints. The mean vesicle diameter present in the isolated fractions was 127 ± 15 nm (Figure 
5.6.A), while the mean number of vesicles/ml was 9.5 x 1010 ± 5.4 x 109 across all timepoints 
(Figure 5.6.B). The combined results of TEM and NTA, demonstrate that successful isolation of 




Figure 5.6. Nanoparticle tracking analysis results across all timepoints. No change in vesicle diameters 
(A) or particles/ ml (B) were noted over time. (ANOVA. Mean ± SEM. n = 9 for BL and 24 hr. n = 8 for 2 
hr). 
A B 
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5.5 Protein concentration of exosomes 
The next aim was to ascertain whether a difference in protein concentration may be present in 
isolated EVs pre and post exercise. No significant changes in protein concentration between 
timepoints were noted (Figure 5.7). 
 
Figure 5.7. Exosome protein concentrations for each timepoint. Protein concentration is represented in 
ng/ µl. (ANOVA. Mean ± SEM n = 8 for BL, n = 7 for 2 hr and n = 8 for 24 hr). 
 
5.6 Qualitative proteome comparison 
A preliminary investigation of whether there may be changes in the types of proteins present in 
exosomes pre and post exercise was done by visually assessing a Coomassie stain of isolated 
exosomes loaded onto a 12 % resolving gel (Figure 5.8). Results suggest that there could be a 
difference in the proteome of exosomes isolated pre and post-exercise, whereby exosomes post-
exercise show a greater band intensity at the ± 50-75 kDa range. Additionally, protein bands 
were more prominent in participant 1 than in participant 2. Notably, also present in exosomes 
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                                             Participant 1                              Participant 2 
 
Figure 5.8. Image of Coomassie stained resolving gel. Electrophoresed exosome proteins of all 
timepoints are displayed for 2 randomly chosen participant (= 6 lanes). Major bands are prevalent at ± 
50, 55, 65, 75 and 300 kDa. (Ladder = BioRad Kaleidoscope). 
 
5.7 EV MicroRNA expression 
miRs are an important biological cargo of exosomes and may have an important role in SkM 
regeneration. Based on results in published literature, five miRs were selected for investigation 
in this study; miR-1, 133a, 133b, 206 and 31. Initial analysis of the miR data demonstrated that 
expression levels for the SkM-specific, miR-206, were diverse. In one participant, expression 
was not detectable at any timepoint, while for another expression was detected at all three 
timepoints. However, most participants exhibited a miR-206 value for at least one timepoint (n 
= 8). In contrast to miR-206, miR-1 was the most abundantly expressed miR, with strong 
expression (Ct < 30) detected in all but one of the 26 samples. miR expression was normalised to 
an exogenous control (cel-miR-39), and expressed as relative expression of their Ct value (i.e. 
ΔCt). ΔCt was converted to - ΔCt so that statistical analysis and graphs would show the 
orientation to denote changes in expression (i.e. larger Ct values correspond to lower miR 
expression. Here, the graphs purely represent expression). Statistical analysis of miR expression 
levels did not reveal any significant difference between timepoints for miR-1 (Figure 5.9.A), 
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31, however, was found to be significantly lower at 24 hr (p < 0.05) post-exercise when 




Figure 5.9. Relative expression of five exosome microRNA levels normalised to the exogenous control, 
cel-miR-39. A-D: relative expression of myomiRs, with no changes noted over time. E: decrease in miR-
31 at 24 hr when compared to BL. Data are represented as relative expression, as - ΔCt. (ANOVA. 
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5.8 Responders vs non-responders 
A disparity in the response of participants to EIMD is a known phenomenon often noted, and 
referred to in the literature as participants being responders or non-responders 22 25 109. To 
ascertain whether this phenomenon may be present in our exosome data, a classification system 
based on vesicle numbers was devised. If a participant had a > 1.5-fold increase in vesicle 
numbers between baseline and 24 hr post-exercise, they were designated as “responders” (n = 
3). In contrast, if they exhibited a decrease in exosome numbers over the same timepoints, they 
were designated as “non-responder” (n = 6). Due to the small number of participants in the 
responder group, no statistical analyses were performed to compare the two groups. However, 
for the non-responder group, a re-analysis of the relative miR expression was performed to see 
if there was an effect of miR content over time in participants who had not released more 
exosomes, but could have released exosomes with a different cargo content. A significant 
change in miR-133a expression was found, whereby it had decreased between BL and 2 hr (p < 
0.05), as well as between BL and 24 hr (p < 0.05) post exercise (Figure 5.10). This miR expression 
change was not found when all participants were grouped together. 
 
 
Figure 5.10. Relative expression changes in miR-133a unveiled after grouping non-responders. Data are 
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Chapter 6: Discussion 
 
This thesis aimed to determine whether an acute bout of muscle-damaging exercise would alter 
the dynamics of circulating exosomes, their protein and selected miR content. It was 
hypothesised that the in vivo model of heavily eccentrically-biased exercise in human volunteers 
would result in substantial changes in systemic communication via exosomes, with the 
numbers, sizes and cargo profile of circulating exosomes changing in parallel, and reflecting a 
skeletal muscle origin. 
6.1 Exercise mode 
Research on circulating exosome responses to exercise is in its infancy, with only a few studies 
published that have investigated the effects of incremental exercise to fatigue 84, aerobic exercise 
lasting 40 mins at 80 % of their VO2max 34 or until a total energy expenditure of 598 kcal 83. There 
are a multitude of exercise modes, intensities and durations that could have been chosen for this 
study. However, there are several reasons that exercise that would inflict muscle damage was 
used: in vitro work has all been done on C2C12s 77 79 80 or PHMs 78 86 cells, these myoblast cells 
are known to respond to eccentrically-biased exercise modes in vivo, including after PMJ 23 and 
DHR 13 24. These data, along with the large size of the muscles used during PMJ and DHR, lead 
us to hypothesise that an eccentrically-biased protocol would likely result in substantial changes 
in systemic communication via exosomes. 
Exosomes are known to be enriched in miRs 41. As mentioned in the introductory section 
(Chapter 3.3.3), myomiRs (as well as miR-31) work in close conjunction with MRFs 17 89 100 101. 
Eccentric exercise is known to cause changes in measures associated with alterations in MRF 
expression levels 10 13, as well as the expression of myomiRs 91. Therefore providing further data 
to substantiate the choice of an eccentrically-biased protocol. 
Indirect evidence for EIMD was achieved through the large increase in serum CK activity and 
PMP following the exercise protocol. A > 5-fold increase in serum CK activity was seen between 
Stellenbosch University  https://scholar.sun.ac.za
37 
 
BL and 24 hr. Notably, elevation in serum CK activity is the most widely used indirect marker 
of EIMD 12. The large elevation in CK activity observed in all participants reinforced confidence 
that the chosen exercise intervention would have activated muscle regeneration processes. This 
is substantiated by van de Vyver et al, who have shown not only a large peak in CK after an acute 
bout of DHR at similar timepoints to those used in this study, but also a concomitant increase in 
SC activation 24 hr post-exercise 13. Similarly, Macaluso et al have shown disruption of sarcomere 
ultrastructure following an acute bout of PMJ 23. From these data, it was concluded that the 
model of EIMD used in this study was sufficient to serve as a putative model for inducing 
significant changes in the profile of circulating exosomes.  
6.2 Qualitative and quantitative analysis of exosomes 
The merit of exosome isolation through SEC was qualitatively shown by the abundance of 
exosomes per field of view in TEM images. As mentioned before, the qEV SEC method 
predominantly isolates EVs within the exosome size range. High-resolution TEM visualisation 
showed that exosomes were rendered intact. Interestingly, the samples did not present with the 
“typical” cup-shaped morphology noted by some research groups 31 57 110. It seems that this cup-
shape noted by some other research groups is likely due to desiccation of the sample, or by 
harsh chemical fixation 111, whereas fresh vesicles were fixed using the negative stain (i.e. uranyl 
acetate) as the fixative in this study. A more comprehensive qualitative analysis of exosomes 
was achieved through visualisation of the exosome-enriched transmembrane protein, CD9, by 
immuno-gold labelling. Regarding the proximity of gold nanoparticles to the exosome 
membrane, we could conclude that CD9+ exosomes were indeed present.  
The number of exosomes derived from participants’ plasma (± 9 x 1010 vesicles/ml) supports the 
notion that these vesicles exist as significant mediators of systemic communication. Recently, 
using isolation and analysis techniques similar to those used here, Gamez-Velero et al determined 
the mean exosome concentration in plasma from four subjects to be 1.9 x 1010  vesicles/ml 112. 
Here we show, using a sample size of 9, a significantly greater mean concentration of 9 x 1010 
vesicles/ml. The infancy of EV biology has left a lack of consensus on nomenclature, isolation 
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techniques and interpretation of results, making comparisons between studies difficult. 
Differences in EV results across studies are often attributed to differences in methodology and 
sample, but this is further confounded by the common variation noted in human studies. 
However, mean exosome diameters differed by just 11 nm between the aforementioned and 
current study (mean diameters of 116 nm and 127 nm, respectively), suggesting the similarity of 
exosome isolation and analysis. Large variability in circulating exosome numbers between 
human participants was seen in both studies.  When considering the deviation from the mean at 
the different timepoints in the current study (SEM. BL: 1.0 x 1010, 2 hr: 8.8 x 109, 24 hr: 8.9 x 109 
vesicles/ml), although also influenced by the relatively small sample size, the inherent variation 
in human measures (such as those seen in CK responses to eccentric exercise) was apparent in 
exosome quantification. One might conclude that variability increases when humans are 
subjected to a physiologically taxing intervention. 
Recently, Gamez-Velero et al were unable to detect exosome protein concentrations using 
standard techniques (Nanodrop and BCA). Similarly, the protein concentrations of SEC-derived 
samples were also below the detection limit of standard quantification techniques. However, 
here the exosome protein concentration was successfully quantified using a microBCA kit. The 
low protein concentrations were also visible on Coomassie-stained gels. Approximately 200 ng 
of exosome protein was the maximum that could be accommodated in each well, far below the 
ug range at which most western blot experiments are performed. Attempts to concentrate 
exosome proteins using a 3 kDa spin column were also unsuccessful (see Appendix 4). The low 
protein concentration, however, is not necessarily indicative of low vesicle numbers, as shown 
by the NTA results. Expressing exosome concentration as vesicles/ ug protein, suggests that a 
low protein content per single vesicle was apparent. Interestingly, results obtained from 
Coomassie stained gels highlighted the presence of proteins (eg. ± 50 and 65 kDa) at post-
exercise timepoints that were not visible at BL. Such a finding suggests that while protein 
concentration of exosomes may not change significantly during the post-EIMD timepoints 
assessed here, the proteome profile of circulating exosomes may still be altered. However, it is 
important to note that this particular set of results was obtained from just two participants for a 
preliminary qualitative view. The future use of more advanced, albeit costly, techniques such as 
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mass spectrometry will need to be applied in the analysis of exosomes pre and post EIMD in 
order for such findings to be properly verified. 
Recently, Webber et al have proposed the representation of exosome concentrations as vesicles 
per ug of protein 113. To better determine the purity of exosome isolates, and suggest the 
potential contamination of unwanted proteins (e.g. from media or serum), they proposed a high 
purity of exosomes to be > 1 x 1010 vesicles per ug protein (derived from serum using 
ultracentrifugation). With the currently reported analysis of minimally perturbed plasma-
derived exosomes using SEC isolation, approximately 2 x 1015 vesicles per ug of protein was 
achieved, suggesting the high purity of the exosome isolate in this study. 
6.3 SkM microRNAs are systemically circulated  
6.3.1 MyomiRs 
The myomiRs, miR-1, 133a, 133b and 206 contents in exosomes were analysed in the current 
study, but did not show any significant relative changes resulting from EIMD. Recently, 
Kramers et al determined a substantial increase in circulating exosome numbers immediately 
after aerobic exercise 84. Within 90 mins, they found that exosome numbers returned to BL 
levels. Considering this, it is plausible that the 2 hr timepoint selected for the current study may 
have missed an immediate systemic response. However, one reason for selecting the 2 hour 
timepoint was that this is a timepoint when the pro-inflammatory response to eccentrically-
biased exercise is most evident 24. 
Nonetheless, the presence of the skeletal muscle-specific myomiR, miR-206, within circulating 
exosomes, gives further insight into the role of skeletal muscle as a systemic communicator. 
This supports the existing knowledge that SkM is very active in the release of cytokines and 
immune activators, dynamically changing this profile following exercise 114. It is clear that the 
understanding of systemic communication with regard to this large tissue will aid in the greater 
understanding of interleaving physiological processes not only involved in muscle biology. 
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6.3.2 The miR-31 axis 
For this study, miR-31 was selected for investigation due to its  known involvement in 
regulation of the myogenic transcription factor, Myf5, at the transcript level 17. Myf5 is an 
important MRF, implicated in the commitment of SC to terminal differentiation, as well as in 
the maintenance of this progenitor cell’s pool size 17. Crist et al have shown that Myf5 protein 
increases in SCs upon activation, with a concomitant decrease in miR-31 expression 17. These 
researchers concluded that Myf5 was “primed” for translation by miR-31 repression at the 
transcript level. Although not assessed here, the timeline of peak SC activation following an 
acute bout of muscle-damaging exercise has previously been shown at 24 hr post-exercise in a 
study using the exercise mode of DHR 13. The lower miR-31 expression within exosomes in the 
current study therefore coincides with this peak activation of SC, and one might speculate 
based on other studies a concomitant increase in Myf5 protein. In support of this “SC, Myf5, 
miR-31 axis”, miR-31 has also been shown to be downregulated during myoblast 
differentiation in vitro 115. Here it was shown the miR-31 component of this axis was released to 
a lesser extent 24 hr post-EIMD, suggesting downregulation may also occur in vivo, at a 
timepoint when Myf5 mRNA repression is likely to decline. 
6.3.3 Responders vs non-responders 
In this study we propose a classification of responders to EIMD through participant response to 
EIMD. As mentioned before, only 3 participants showed an exosome increase > 1.5-fold 24 hr 
post-exercise. Here we show that when re-analysis of miR data was done on non-responders (n 
= 6), miR-133a showed a significant decrease in exosomes at 2 hr and 24 hr post-exercise, a 
finding that was not apparent when all participants were analysed together. These findings 
suggest that participant response groupings may be an important factor to consider in EV and 
miR analysis. 
6.4 Conclusion 
Systemic intercellular communication is not a new concept. A plethora of information on the 
dynamics of circulating hormones, cytokines and peptides is available for a host of different 
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states in vivo. In contrast, the understanding of exosome dynamics is only just beginning to be 
unraveled. Due to their recent emergence, small size and limited cargo, exosome analysis lies at 
the very edge of current technology. The current interpretation of exosome dynamics and 
profiles will therefore most likely develop slowly with each new study, adding only a few 
answers whilst raising even more questions to be answered. 
Using SEC as an exosome isolation method, along with a simplified protocol for fast exosome 
visualisation using TEM, and quantification using NTA, this study was the first to probe the 
effects of eccentrically-biased exercise on exosome dynamics in human subjects. Using the 
combination of techniques here, it can be concluded that isolation of exosomes was successful 
based on the expected size range and the intact nature of vesicles visualised. The two main 
biological findings were a) that circulating exosome numbers differ substantially between 
human subjects, both prior and after a taxing intervention and b) that a 22 nucleotide 
microRNA, miR-31, is decreased within exosomes in response to the physiologically intensive, 
non-invasive perturbation that induced symptoms of exercise-induced muscle damage. 
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Chapter 7: Limitations and future 
directions 
 
It is clear from this study that the analysis of human samples can be considerably variable, a 
point that is emphasised by disparate responses of participants to exercise. As noted in this 
study and in the literature, EIMD delineates groups of responders and non-responders to 
muscle damage based on the CK responses 22 25 109. In this study we propose a new grouping 
system based on changes in exosome numbers, with participants showing > 1.5-fold increase at 
24 hr post-exercise being grouped as responders, and those showing a decrease being grouped 
as non-responders. However, our groupings revealed just 3 participants in the responders 
group, greatly decreasing statistical power for subsequent exosome miR content comparison. 
Future studies would benefit from greater participant numbers that would help resolve 
definitive groupings, and perhaps provide a partial description for the variable responses to 
EIMD seen in humans. 
Briefly mentioned in the introduction section, no single indirect indicator of muscle damage can 
be taken as an absolute measure. Visualisation of sarcomere damage from muscle biopsies can 
be used to directly indicate damage, but a combination of strategies is necessary for indirect 
measures. Muscle biopsies were not taken in this study as the biopsy procedure could 
potentially cause changes in skeletal muscle exosome release and subsequent analysis of the 
circulating exosomes. Measurements of force output were not done for this same reason. Here, 
the use of serum CK activity and PMP could be improved upon with the addition of circulating 
inflammatory marker analysis (at the minimum, IL-6) and the measurement of isometric force 
loss, aiding confirmation of EIMD. However, it remains true that muscle damage can only be 
accurately validated in muscle biopsies themselves. 
Although the proximity of immuno-gold to the membrane of exosomes was not present on 
grids incubated with the immuno-gold conjugated secondary alone, significant non-specific 
binding to the TEM grid was noted. This non-specific binding was likely due to the high 
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concentrations of secondary used (i.e. 1 : 50). Nonetheless, further optimization and analysis of 
exosome immuno-labelling will be required to definitively determine the presence of CD9 on 
exosome membranes.  
In the current investigation, blood draw timepoints were chosen in accordance with known 
changes in SkM-related events in circulation. The 2 hr post-exercise timepoint was chosen in 
accordance with peak elevation in the inflammatory cytokine, IL-6, from a similar DHR protocol 
24. Similarly, the 24 hr timepoint was chosen in knowledge that peak satellite cell, as shown by 
an increase in Pax 7+ cells, in muscle biopsies taken after a similar DHR regimen is seen at that 
timepoint 13. The study by Fruhbeis et al later revealed a large increase in exosome numbers 
immediately following an acute bout of aerobic exercise 84, a timepoint that was not used in this 
study. Additionally, Banzet et al found an increase in circulating myomiRs at 6 hr after an acute 
bout of eccentrically-biased exercise. However, EVs were not taken into account with these 
myomiR changes. Although the two aforementioned studies cannot directly be translated into 
the context of this study i.e. use of aerobic exercise and non-EV related myomiRs changes, 
respectively, it is nonetheless important for researchers to consider additional timepoints to 
more comprehensively determine the dynamics of circulating EVs e.g. BL, immediately post-
exercise, and at 1, 2, 6 and 24 hr post-exercise. 
As with EVs, research on miRs is also still in its infancy. miR analysis and reporting of miR data 
lacks consensus regarding representation of data, use of controls (exogenous and endogenous) 
and quantification. The analysis of miRs in this study was greatly aided by established 
knowledge on the analysis of larger RNA species in our lab. This study made use of the new 
TaqMan Advanced workflow (ThermoFisher Scientific) for miR analysis. This workflow was 
released in 2015, and we are the first to use it in South Africa. Few studies have been published 
using this workflow, and to our knowledge, none on exosome miRs. This makes comparison of 
data difficult. Additionally, the use of exogenous controls such as in this study only controls for 
qPCR variation, and the identification and validation of an endogenous miR control would 
greatly improve the interpretation of the miR results. However, as opposed to GAPDH which is 
used as an endogenous control for mRNA qPCR, no appropriate endogenous miR control has 
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yet been identified. Regardless of the workflow chosen or the control used, it is apparent in the 
literature that isolation, analysis and representation of miRs is disparate. More stringent 
guidelines need to be established by the scientific community as the field progresses. 
Lastly, although much research is now directed toward the analysis of miR-206 in circulation, 
quantification is reported as difficult and variable 91. Indeed, in the current study, just one 
participant exhibited a miR-206 value at each timepoint, with one participant having no value at 
any of the timepoints. The tissue-specific nature of this miR undoubtedly holds great potential 
in unlocking the intricacies of SkM as a systemic communicator, but it appears that even the 
basics of miR-206 are far from understood, let alone other myomiRs in relation to miR-206 and 
the effects of physiologically taxing interventions in otherwise healthy individuals. Therefore, in 
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Appendix 1: microRNA biogenesis, 
nomenclature & function 
 
Biogenesis 
microRNAs (miRs) are either encoded in their own loci in intergenic regions, or from within the 
introns of other genes 98. RNA polymerase 2 is an important enzyme that transcribes these loci 
into RNA transcripts, which immediately fold back on each other to form primary miRs. 
Cleavage by the enzymes drosha and DGCR8 (DiGeorge syndrome critical unit 8) inside the 
nucleus results in a 60-70 base pair stem-loop structure, termed precursor miR. This precursor is 
exported out of the nucleus and cleaved into two ± 22 nucleotide mature miR transcripts (from 
here on referred to as miRs) by the enzyme dicer. One mature miR is then selectively 
incorporated into a conglomeration of proteins known as an RNA-induced silencing complexes 
(RISC), whilst the other is tagged for degradation. RISC proteins facilitate miRs in their 
repression on mRNA 98. 
Nomenclature 
miRs are named according to their position on their stem loop precursor; either at the 5p or 3p 
end (i.e. miR-133a-3p vs miR-133a-5p). Due to poorly understood mechanisms, one of these 
transcripts is often expressed at a lower level (designated by a *), and it is even possible that one 
of the transcripts may not be present at any level whatsoever. However, it is important to note 
that an “unseen” mature miR could be due to our lack of a unified miR understanding, or from 
imperfect measurement techniques. Furthermore, it is conceivable that these miRs* are fast 
acting, or only present in certain species. Many miRs can be categorised into families with 
similar structure and, seemingly, function – serving as a guideline for the mapping of miR 
activities. Fairly regularly, two miRs from completely different chromosomes can result in 
sequences that differ by just one nucleotide. These almost identical miRs are denoted with the 
suffix a or b (i.e. miR-133a vs miR-133b). Similarly, and perhaps most astonishingly, is that miRs 
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can result in the exact same, indistinguishable sequence despite having originated from 
separate chromosomes. Furthermore, these two transcripts can be processed from different 
areas of their stem loop precursors. Although this phenomenon may demonstrate some 
redundancy, it is interesting to consider that two identical miRs have converged from distinct 
evolutionary pathways. These identical miRs are labelled with the suffix 1 or 2 (i.e. miR-1-1 vs 
miR-1-2). 
Function 
In humans, miRs exert their effects through the transient repression of mRNA translation. They 
do this by incomplete/ “uncomplimentary” binding, and it is currently thought that the miR 
seed sequence (approximately 6-8 nts at the 5’ end) is of most importance in recognizing 
mRNAs with some specificity 115. On the other hand, most plant miRs bind with complete 
complementarity, and seemingly always result in mRNA degradation. Human miRs therefore 
have the unique ability to target multiple mRNA transcripts, and consequently, predictive tools 
regularly establish approximately 300 proposed targets per miR. It is now well known that one 
mRNA can be targeted by more than one miR, and it is possible for one miR to bind one mRNA 
at multiple sites. This convolution of information makes prediction of functional outcomes, or 
the establishment of definitive miR roles, challenging, and therefore miRs can only truly be 
analysed through gene expression and chromatin-immunoprecipitation studies for now. 
Circulating-miRs 
Due to blood containing an abundance of RNases, it is easy to accept that RNA is somehow 
protected within circulation (i.e. within EVs). This knowledge is attractive to many different 
researchers, such as those looking at; biomarkers for disease, inter-organ communication, 
regeneration, normal physiology, and even therapeutics. Particular interest lies within the 
ability to capture actively secreted genetic material, which could potentially provide a novel 
level of interpretation in physiology. The emerging field of this type of cellular communication 
has been termed “horizontal gene transfer” 116. 
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The known existence of miRs within EVs, and the understanding of their known regulatory 
effects has greatly propagated their interest. There are now over 2500 human miRs identified as 
per miRBase v.20. (January 2015), whereas most of them are ubiquitously expressed, only a few 
are tissue specific or enriched 117 118. miRs that are tissue-specific are defined as those 20-fold 
more prevalent in that particular tissue 118. Muscle-specific miRs are termed myomiRs, and only 
seven have been identified to date 119. Five are present in both cardiac and skeletal muscle, 
whereas each muscle type has only one that is specific. miR-206 is the skeletal muscle-specific 
miR, and its identification within EVs therefore gives researchers the opportunity to identify 
circulating EV cargo released from skeletal muscle explicitly. 
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Appendix 2: microRNA workflow 
discussed 
 
The TaqMan Advanced microRNA workflow (ThermoFisher Scientific) is optimised for the 
analysis of multiple mature miRs of limited quantity or in a dilute isolate. The use of this 
workflow is therefore well suited to the analysis of miRs from biofluids, such as human plasma. 
Total RNA isolation 
The Total Exosome RNA and protein isolation kit makes use of acid-phenol:chloroform 
extraction with separation through centrifugation, to delineate proteins and lipids (in the 
organic phase) from nucleotides (in the aqueous phase). The use of acidic phenol allows for 
RNA to exclusively occupy the aqueous phase, pulling DNA into the organic phase. The acidic 
nature of the solution causes the more negatively charged DNA strands to be preferentially 
neutralized, and hence, more readily precipitated.  
The resulting RNA-containing aqueous phase is then loaded onto a glass-fibre filter column. 
The negatively charged (i.e. due to prevalent phosphate groups) RNA strands, is immobilized 
on positively charged glass-fibre filters by brief centrifugation at high speeds (i.e. 10 000 g). 
Small RNAs can be enriched through a second isolation step, making use of a change in the 
proportion of reagents (i.e. salts and ethanol). RNA is then eluted through the columns using a 
low ionic strength buffer (i.e. nuclease-free water). 
Reverse transcription 
The TaqMan Advanced miR cDNA Synthesis kit uses poly(A) tailing, adaptor ligation, reverse 
transcription and amplification to achieve sufficient cDNA for subsequent qPCR. 
The first step of the cDNA synthesis involves the addition of multiple Adenosine nucleotides to 
the 3’ end of all RNA in the sample, using a poly(A) polymerase (Figure A.1.A). Ligases then 
add a synthetic adaptor sequence to the 5’ end of RNAs that contain a phosphate group at this 
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site (Figure A.1.B). In this way, only mature microRNAs are selected. Precursor miRNAs have a 
2 nucleotide overhang on the 3’ end, cloaking their 5’ phosphate. This new nucleotide construct 
is then reverse transcribed by a universal reverse transcriptase and forward and reverse primer 
recognising the poly(A) tail and adaptor sequence of the construct (Figure A.1.C). This new 
construct is now “tagged” on both the 3’ and 5’ ends and can be amplified prior to qPCR with 
universal forward and revers primers (Figure A.1.D). 
 
Figure A2. Schematic showing phases of microRNA preparation for subsequent reverse 
transcription. A: poly (A) tailing of sample microRNA. B: ligation of adaptor sequence. C: 
conversion of construct into a complimentary sequence. D: amplification of construct with 
universal primers. Image taken from TaqMan Advanced miR assay user guide (ThermoFisher 
Scientific). 
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Quantitative Polymerase Chain Reactions 
Quantitative polymerase chain reactions on the resultant cDNA are achieved through the use of 
specific TaqMan Advanced miR probe. The specificity of TaqMan probes avoids potential 
primer dimers and non-specific binding sometimes experienced with the use of SYBR green. 
TaqMan Advanced miR assays are available for all mature human miRs mentioned in version 
21 of miRBase. These primers are made up of; a complimentary nucleotide sequence to a 
specific miR target, a fluorescent reporter dye (i.e. FAM), a non-fluorescent quencher (NFQ) and 
a minor groove binder (MGB). Presently, TaqMan Advanced primers only contain the blue 
reporter dye, FAM, at their 5’ end, preventing multiplexed analysis. The 3’ quencher molecule’s 
proximity to the fluorescent dye allows for the absorption of excited electrons, and thus inhibits 
the release of fluorescence. Therefore, it is only possible to detect fluorescence after Taq 
polymerases has cleaved the reporter dye and the quencher from the probe. Their loss of 
proximity means that fluorescence can now be emitted, and is the reason for TaqMan probe’s 
specificity. In addition, the 3’ end makes use of a minor groove binder (MGB) which increases 
the melting temperature, which can be used to analyse the specificity of primer binding through 
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Appendix 3: A brief comparison of EV 
isolation techniques 
 
The substantial diversity of EV isolation techniques apparent in the published literature, makes 
the comparison of data between labs and studies difficult. A consensus on the best, or most 
suitable isolation method is not yet agreed upon. An absolute method may not be possible, as 
many research teams have shown that downstream applications vary considerably depending 
on the method of iolation 120 112 121 122. A brief overview of the advantages and disadvantages of 
the different EV isolation methods is show in Table A3. Isolation methods that often appear in 
the literature can be broadly grouped into; differential centrifugation, density gradients, 
chemical precipitation, immune-affinity and size exclusion 123.  
1. Differential centrifugation 
With differential centrifugation, multiple spins are used to rid the sample of cells and debris, 
after which the sample is ultracentrifuged at high speeds (i.e. > 100 000 g) to pellet the EVs. This 
is currently the most widely used method and is considered the gold standard in EV isolation. 
High speed centrifugation was used in the initial EV discoveries 36. It is now commonplace for 
researchers to combine ultracentrifugation with sequential steps of filtration (i.e. 0.22-0.45 µm 
pore size filters) to differentiate between microvesicles and exosomes.  
2. Density gradients 
More recently, differential centrifugation has been supplemented with sucrose or Iodixanol 
(OptiPrep) gradients, and sucrose cushions to achieve a more resolved isolate of greater purity. 
This method makes use of the known EV density range of 1.1 - 1.9 g /ml, resulting in 
fractionation of the sample per density, rather than size.  
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 Advantages Disadvantages 
Differential 
centrifugation 
Widely used and therefore 
translatable. Inexpensive. 
Requires large equipment. 
Time-consuming. Aggregation 
of EVs. 
Density gradients High specificity. Low contamination. Inexpensive. 
Isolation of an undefined EV 
subpopulation. Difficult to 
perform. Time-consuming. 
Chemical precipitation Easy to use. Inexpensive. Non-specific. Potential high contamination 
Immune-affinity High specificity. 
Isolation of an undefined EV 
subpopulation. Dependent on 
antibody quality. Expensive. 
Size exclusion Short isolation time. Easy to use. Expensive. Dilutes sample. 
Table A3. Comparison of commonly used extracellular vesicle isolation techniques. 
 
3. Chemical precipitation 
EV precipitation using precipitating polymers (eg. Polyethylene glycol, ExoQuick, Total 
Exosome Isolation Reagent) has gained popularity of late. Many researchers have favored this 
technique due to its low cost and ease of use 120. The use of precipitating polymers is a well-
established technique in the isolation of viral particles. These polymers readily neutralise the 
charge of biomolecules, thereby decreasing their solubility and causing them to precipitate. 
However, others have highlighted the potential of this precipitation method to co-isolate a 
significant amount of contaminating protein due to its non-specific nature 124.  
4. Size exclusion 
The use of size exclusion columns for the isolation of EVs is an technique that is rapidly 
increasing in popularity, largely due to its passive isolation of EVs. Most size exclusion 
techniques make use of Sepharose (GE Healthcare Life Sciences), a bead-based form of the 
common cross-linking polymer, Agarose. Size exclusion columns (SEC) can also be used to 
resolve EV fractions derived from other methods. Alternatively, SEC can be used as a 
standalone technique. Due to the passive nature of SEC EV isolation, the potential for this 
method to yield intact and functional vesicles is high. The small size of the SEC columns makes 
Stellenbosch University  https://scholar.sun.ac.za
60 
 
them suitable for use in any lab and does not necessitate access to an expensive ultracentrifuge. 
Additionally, these columns are known to result in a low amount of contaminant protein co-
isolation. 
5. Immune-affinity  
Immune-capture, or immune-affinity, using conjugated antibodies, is a multidisciplinary 
technique. This isolation technique includes the use of flow cytometry, magnetic beads or 
precipitant-conjugated antibodies to capture specific subgroups of EVs in an isolate. 
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Appendix 4: Concentrating SEC-derived 
exosome fractions 
 
One drawback of size exclusion columns as an exosome isolation technique is the dilution of 
sample. SEC uses passive filtration of sample through Sepharose-loaded columns, by adding 
PBS to follow the sample. The resultant eluent, although resolved, is significantly diluted in 
PBS. This dilution makes some downstream analyses difficult eg. protein concentration often 
can’t be detected through standard techniques and isolated total RNA cannot be accurately 
quantified. For these reasons, we attempted to concentrate the SEC-isolated exosome samples. 
Pooled fractions (fractions 7-9) were concentrated using 3kDa pore-size, Amicon spin columns 
(Merck Millipore). These columns were centrifuged at 4 000 g until sufficient sample had eluted 
through. Approximately 500 µl was loaded per column, and the resultant concentrate was ± 150 
µl. Concentrated samples were visualised on TEM grids (Figure A4.1), and displayed obvious 
signs of exosome aggregation. Exosomes are known to be enriched in cell adhesion molecules 
and proteins associated with fusion 30. It is therefore expected that their forced proximity, 
through concentration, would result in aggregation. 
 
 
Figure A4.1. TEM image of aggregated exosomes following sample concentration. 
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We then went on to visualise the concentrated exosome proteins in a Coomassie-stained gel 
(Figure A4.2). No change in protein content was apparent between normal and concentrated 
samples across all timepoints, suggesting that the sample concentration was unsuccessful.  
 
The difficulty in protein determination, quantification and concentration seen in this study, 
highlights the need for more advanced proteomic techniques, such as mass spectrometry, to 
better understand the proteome of SEC-derived exosomes. 
 
  
                                                               Normal                   Concentrated 
 
Figure A4.2. Coomassie-stained gel showing normal vs concentrated exosome samples from one 
participant. Protein from all timepoints was loaded, and no obvious change in protein could be 
seen. 
BL 2 hr BL 24 hr 2 hr 24 hr 
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Appendix 5: Nanoparticle tracking 
analysis theory 
 
Nanoparticle tracking analysis (NTA) monitors the inherent motion of microscopic particles in 
liquid suspension, termed brownion motion. Brownion motion describes the random 
movement of particles in liquid suspension, resulting from constant interactions with 
surrounding molecules. Individual particles are tracked based on their dynamic light scattering 
of a laser beam (Figure A5). Particle size can be determined at just 20 X magnification, by 
satisfying the criteria of the Stokes-Einstein equation. The equation necessitates that the 
particles are suspended in a liquid of uniform temperature and viscosity. Particle sizes can then 
be determined by the speed at which they move, with smaller particles moving faster. Particle 
numbers (expressed as particles/ml) are extrapolated to the volume of the undiluted, original 
sample. For sufficient statistical power, vesicle sizes and numbers are determined across 5 x 30 
second videos. 
 
Figure A5.  An example of a still image taken from a sample NTA video. 
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